<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id><journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id><journal-id journal-id-type="publisher-id">ci</journal-id><journal-id journal-id-type="coden">jcisd8</journal-id><journal-title-group><journal-title>Journal of Chemical Information and Modeling</journal-title></journal-title-group><issn pub-type="ppub">1549-9596</issn><issn pub-type="epub">1549-960X</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39933881</article-id><article-id pub-id-type="pmc">PMC11863370</article-id>
<article-id pub-id-type="doi">10.1021/acs.jcim.4c02158</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>OpenMMDL</italic> - Simplifying the Complex:
Building, Simulating, and Analyzing Protein&#x02013;Ligand Systems
in <italic>OpenMM</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Talagayev</surname><given-names>Valerij</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref><xref rid="notes1" ref-type="notes">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Chen</surname><given-names>Yu</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref><xref rid="notes1" ref-type="notes">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Doering</surname><given-names>Niklas Piet</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref><xref rid="notes1" ref-type="notes">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Obendorf</surname><given-names>Leon</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref><xref rid="aff2" ref-type="aff">&#x000b6;</xref><xref rid="notes1" ref-type="notes">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Denzinger</surname><given-names>Katrin</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Puls</surname><given-names>Kristina</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Lam</surname><given-names>Kevin</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath8"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8834-3881</contrib-id><name><surname>Liu</surname><given-names>Sijie</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath9"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5682-1815</contrib-id><name><surname>Wolf</surname><given-names>Clemens Alexander</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Noonan</surname><given-names>Theresa</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath11"><name><surname>Breznik</surname><given-names>Marko</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath12"><name><surname>Knaus</surname><given-names>Petra</given-names></name><xref rid="aff2" ref-type="aff">&#x000b6;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath13"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5344-0048</contrib-id><name><surname>Wolber</surname><given-names>Gerhard</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02021;</label>Department
of Biology, Chemistry and Pharmacy, <institution>Institute
of Pharmacy, Molecular Design Group</institution>, K&#x000f6;nigin-Luisestr. 2 + 4, 14195 Berlin, <country>Germany</country></aff><aff id="aff2"><label>&#x000b6;</label>Department
of Biology, Chemistry and Pharmacy, <institution>Institute
of Biochemistry, Signal Transduction Group</institution>, Thielallee 64, 14195 Berlin, <country>Germany</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>gerhard.wolber@fu-berlin.de</email>. Phone: <phone>+49 30 838 52686</phone>. Fax: <fax>+49 30 838 452686</fax>.</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>02</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>24</day><month>02</month><year>2025</year></pub-date><volume>65</volume><issue>4</issue><fpage>1967</fpage><lpage>1978</lpage><history><date date-type="received"><day>21</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>01</month><year>2025</year></date><date date-type="rev-recd"><day>21</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0006" id="ab-tgr1"/></p><p>Molecular dynamics (MD) simulations have become an essential
tool
for studying the dynamics of biological systems and exploring protein&#x02013;ligand
interactions. <italic>OpenMM</italic> is a modern, open-source software
toolkit designed for MD simulations. Until now, it has lacked a module
dedicated to building receptor&#x02013;ligand systems, which is highly
useful for investigating protein&#x02013;ligand interactions for drug
discovery. We therefore introduce <italic>OpenMMDL</italic>, an open-source
toolkit that enables the preparation and simulation of protein&#x02013;ligand
complexes in <italic>OpenMM</italic>, along with the subsequent analysis
of protein&#x02013;ligand interactions. <italic>OpenMMDL</italic> consists
of three main components: <italic>OpenMMDL Setup</italic>, a graphical
user interface based on Python <italic>Flask</italic> to prepare protein
and simulation settings, <italic>OpenMMDL Simulation</italic> to perform
MD simulations with consecutive trajectory postprocessing, and finally <italic>OpenMMDL Analysis</italic> to analyze simulation results with respect
to ligand binding. <italic>OpenMMDL</italic> is not only a versatile
tool for analyzing protein&#x02013;ligand interactions and generating
ligand binding modes throughout simulations; it also tracks and clusters
water molecules, particularly those exhibiting minimal displacement
from their previous coordinates, providing insights into solvent dynamics.
We applied <italic>OpenMMDL</italic> to study ligand&#x02013;receptor
interactions across diverse biological systems, including LDN-193189
and LDN-212854 with ALK2 (kinases), nifedipine and amlodipine in Ca<sub><italic>v</italic></sub>1.1 (ion channels), LSD in 5-HT<sub>2B</sub> (G-protein coupled receptors), letrozole in CYP19A1 (cytochrome
P450 oxygenases), flavin mononucleotide binding the FMN-riboswitch
(RNAs), ligand C08 bound to TLR8 (toll-like receptor), and PZM21 bound
to MOR (opioid receptor), highlighting distinct functionalities of <italic>OpenMMDL</italic>. <italic>OpenMMDL</italic> is publicly available
at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/wolberlab/OpenMMDL">https://github.com/wolberlab/OpenMMDL</uri>.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Sonnenfeld Stiftung</institution><institution-id institution-id-type="doi">10.13039/100010121</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>International Max Planck Research School for Biology and Computation, Max Planck Society</institution><institution-id institution-id-type="doi">NA</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Friedrich Naumann Stiftung</institution><institution-id institution-id-type="doi">10.13039/501100007443</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>China Scholarship Council</institution><institution-id institution-id-type="doi">10.13039/501100004543</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id institution-id-type="doi">10.13039/501100001659</institution-id></institution-wrap></funding-source><award-id>DFG-SFB1444</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id institution-id-type="doi">10.13039/501100001659</institution-id></institution-wrap></funding-source><award-id>435233773</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ci4c02158</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ci4c02158</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Molecular dynamics (MD) simulations have
become an essential tool
for conformational sampling of biological systems,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> protein&#x02013;protein interactions<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> and dynamics of protein&#x02013;ligand interactions.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Various MD software packages, including <italic>Amber</italic>,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup><italic>Gromacs</italic>,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup><italic>CHARMM</italic>,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup><italic>NAMD</italic>,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> and <italic>Desmond</italic>(<xref ref-type="bibr" rid="ref8">8</xref>) have been developed, each with unique
benefits and drawbacks. Though these packages offer diverse features,
they face extensibility challenges, with new methods often delayed
by developers favoring specific tools. To address this, <italic>OpenMM</italic>(<xref ref-type="bibr" rid="ref9">9</xref>) was developed as a community-driven
tool, with customizable force fields, Python integration, and GPU
acceleration. However, it lacks built-in easy preparation of protein&#x02013;ligand
simulations, limiting its use in drug discovery. To address this issue,
users must rely on tools from third-party packages<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> for
ligand parametrization and wrapping. Despite the availability of helpful
tutorials such as <italic>TeachOpenCADD</italic>,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> setting up receptor&#x02013;ligand simulations remains complex,
especially for noncoders or those with less MD experience. The development
of user-friendly solutions was inspired by the need to simplify complex
computational pipelines for broader accessibility. Our focus was on
using and extending <italic>OpenMM Setup</italic>,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> a graphical user interface (GUI) developed by <italic>OpenMM</italic> developers.</p><p>Among the tools available for analyzing MD simulations,<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref></sup> Python-based libraries such as <italic>MDAnalysis</italic>,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup><italic>MDTraj</italic>,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and <italic>HTMD</italic>(<xref ref-type="bibr" rid="ref17">17</xref>) stand
out for their seamless integration with Python-based simulation tools,
like <italic>OpenMM</italic>.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> However,
these libraries often lack a focus on protein&#x02013;ligand interactions,
a critical area for many studies. In order to address this, GUI-based
tools like <italic>OpenMMDL</italic> require the integration of additional
packages like the Protein&#x02013;Ligand Interaction Profiler (<italic>PLIP</italic>),<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> which analyzes protein&#x02013;ligand
complexes, defining interactions based on functional groups, distances,
and angles.</p><p>Although the stability of ligand-protein interactions
is often
assessed by tracking their movements in MD trajectories, time-resolved,
interaction-based analyses offer novel insights.<sup><xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref22">22</xref></sup> Tools such
as <italic>Dynophores</italic>(<xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref25">25</xref>) provide such analyses by applying abstraction layers to <italic>LigandScout</italic>&#x02019;s<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> interaction
calculations. This approach considers atomic hybridization alongside
geometrical features essential for chemical interactions. Another
method, Protein&#x02013;Ligand Interaction Fingerprints (<italic>ProLIF</italic>),<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> uses SMARTS patterns<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> that identify interacting atom groups, evaluating the plausibility
of interactions based on distances and angles. Interaction analyses
often do not take into account water-mediated interactions, which
are crucial to understanding the specificity and affinity of small
molecule binding. Although certain tools<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> have been developed, most lack simple integration into open-source
MD pipelines.</p><p>We present <italic>OpenMMDL</italic>, a novel
tool that extends <italic>OpenMM</italic>, with a particular focus
on the efficient preparation
of protein&#x02013;ligand complexes for simulation. Furthermore, <italic>OpenMMDL</italic> incorporates integrated analysis tools for investigating
molecular interactions and water kinetics. Designed with an emphasis
on user-friendliness and extensibility, <italic>OpenMMDL</italic> is
well-positioned to support a diverse array of applications in molecular
dynamics, especially within the realm of computational drug design.</p></sec><sec id="sec2"><title>Implementation</title><sec id="sec2.1"><title><italic>OpenMMDL Setup</italic></title><p>The <italic>Flask</italic>-based<sup><xref ref-type="bibr" rid="ref30">30</xref></sup><italic>OpenMMDL Setup</italic> provides access to a web-based GUI through any browser, offering
two options for preparing an MD simulation. Simulations can be initiated
either by directly using Amber input files or by starting with protein
PDB and ligand SDF files, which can then be processed with <italic>PDBFixer</italic>(<xref ref-type="bibr" rid="ref9">9</xref>) or <italic>AmberTools</italic>(<xref ref-type="bibr" rid="ref4">4</xref>) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Schematic representation of simulation file preparation
using <italic>OpenMMDL Setup</italic>. Two preparation options are
featured: <italic>PDBFixer Preparation</italic> and <italic>AmberTools
Preparation</italic>. The preparation process begins with file uploading.
The <italic>AmberTools Preparation</italic> has the option to upload
the <italic>Amber</italic> topology and coordinate files, which leads
directly
to the final page with the simulation configuration. With the option
to upload PDB files, the subsequent steps involve preparing the structure,
building the system, and configuring the simulation settings. This
results in the delivery of an MD simulation script, which serves as
input for <italic>OpenMMDL Simulation</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0001" id="gr1" position="float"/></fig><sec id="sec2.1.1"><title><italic>PDBFixer Preparation</italic></title><p><italic>OpenMMDL</italic>&#x02019;s <italic>PDB Preparation</italic> integrates <italic>PDBFixer</italic>,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> a package for PDB file preparation
and <italic>RDKit</italic>,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> an open-source
chemoinformatics toolkit applied in drug discovery and computational
chemistry to allow system setup from PDB and SDF file inputs. <italic>PDBFixer</italic> addresses missing residues and heavy atoms, while <italic>RDKit</italic> is used for ligand minimization and sanitization.
Subsequently, <italic>OpenMMDL Setup</italic> allows force field and
water model selection, which are automatically applied to ensure seamless
compatibility with <italic>OpenMM</italic>, along with water box and
membrane customization.</p></sec><sec id="sec2.1.2"><title><italic>AmberTools Preparation</italic></title><p>The <italic>AmberTools Preparation</italic> generates <italic>Amber</italic> topology
and coordinate files from separate ligand and protein PDB input structures,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> allowing to choose the force fields for both
protein and ligand. <italic>Antechamber</italic>,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> designed to work with GAFF,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> plays a crucial role in the generation of ligand parameter files.
Furthermore, the preparation enables the inclusion of GAFF-incompatible
ligands, such as porphyrins. These ligand parameters are provided
in the <italic>Amber</italic> parameter database.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> The system can also include a water box and a membrane,
with the option of a membrane mixture with varying lipid ratios. This
is achieved using <italic>PACKMOL-Memgen</italic>.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> A preparation script can be executed to generate topology
and coordinate files, which serve as input for subsequent MD simulations.</p></sec><sec id="sec2.1.3"><title>Simulation Configuration</title><p>The simulation configuration
determines simulation duration and frame count, as well as the output
parameters that generate a data log file detailing specifics including
the simulation progress. Checkpoint files, vital for restarts, are
generated at a predefined 0.02 ns interval, and are modifiable. Postprocessing
options include topology and trajectory file format selection. Output
choices allow the definition of atoms to be included. The configuration
also facilitates the execution of <italic>OpenMMDL Analysis</italic> on the final output with customizable default analysis parameters,
along with offering options for simulation, integrator settings,
and modification capabilities. Finally, a Python script is generated,
which serves as the input for <italic>OpenMMDL Simulation</italic>.</p></sec></sec><sec id="sec2.2"><title><italic>OpenMMDL Simulation</italic></title><p><italic>OpenMMDL
Simulation</italic> facilitates the simulation of protein&#x02013;ligand
complexes from <italic>OpenMMDL Setup</italic>. The input supports
PDB topology files with ligand files in SDF and MOL2 format. For the
output of the <italic>PDBFixer Preparation</italic> module, <italic>RDKit</italic>(<xref ref-type="bibr" rid="ref10">10</xref>) adds necessary hydrogens
and edits chiral atoms, with optional energy minimization using the
MMFF94 force field.<sup><xref ref-type="bibr" rid="ref35">35</xref>&#x02212;<xref ref-type="bibr" rid="ref41">41</xref></sup> The ligand is then converted to an <italic>Open Force Field</italic> Molecule<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> and subsequently to an <italic>OpenMM</italic> object,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> to ensure coordinate
correctness. <italic>PDBFixer</italic>(<xref ref-type="bibr" rid="ref9">9</xref>) reads the protein topology and facilitates its merging with the
ligand using <italic>MDTraj</italic>.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> The resulting complex is solvated using the specified water model
and ions. Upon selection of padding options, a membrane is added accordingly.
The output of the <italic>AmberTools Preparation</italic> utilizes
the generated <italic>Amber</italic> topology and coordinate files,
requiring no additional modifications. The simulation begins with
an energy minimization step, followed by system equilibration and
subsequent simulation.</p><sec id="sec2.2.1"><title>Simulation Postprocessing</title><p>Postprocessing is performed
by <italic>OpenMMDL Simulation</italic>. The protein&#x02013;ligand
complex is centered inside the water box using <italic>MDTraj</italic>(<xref ref-type="bibr" rid="ref16">16</xref>) and the complex and water box are repositioned
to maintain the initial coordinates with <italic>MDAnalysis</italic>,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> both packages being used for MD simulation
analysis. The final postprocessing step aligns the protein and ligand
with the initial topology, preventing undesirable rotation. The final
result is an analysis-ready trajectory (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Simulation workflow overview. The simulation
workflow involves
combining the topologies of the protein, ligand, and cofactor to obtain
the prepared system with the desired water model and membrane, if
selected. The prepared system undergoes MD simulation to generate
the MD simulation output. This output is then postprocessed to generate
an aligned protein that is centered in the solvent with the initial
coordinates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0002" id="gr2" position="float"/></fig></sec></sec><sec id="sec2.3"><title><italic>OpenMMDL Analysis</italic></title><p><italic>OpenMMDL
Analysis</italic> allows users to obtain multiple analytical metrics
from their MD trajectory. These metrics include root-mean-square deviation
(RMSD) calculations of the protein backbone and ligand, as well as
receptor&#x02013;ligand interaction features. These are used to generate
binding modes - fingerprints of interaction combinations in a certain
frame. <italic>OpenMMDL</italic> also offers options for 2D and 3D
visualization of molecular interactions. Additionally, <italic>OpenMMDL</italic> clusters stable waters, defined by a movement of less than 1 &#x000c5;
between consecutive frames (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>).</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>(A) The stable water analysis reveals clusters of water
molecules
that remain stable between two consecutive frames. The clusters in
this example have a maximum distance of 1 &#x000c5; (cluster EPS = 1.0)
between each core member in at least 25% of the MD simulation. (B)
The transition graph displays the individual binding modes, their
occurrence frequency, and the transition percentage between them.
The transition between binding modes is characterized using two values:
the occurrence of the transition (transition/amount of frames) and
the probability of the transition for the binding mode (transition/binding
mode occurrence). Additionally, the self-loop probability of the binding
mode, and thus the transition itself, is also displayed. (C) On the
left, there is a &#x0201c;barcode&#x0201d; representation of interactions
over the course of an MD trajectory. The chart on the right displays
the total interaction frequency as a percentage. In the center, a
point cloud representation of interactions over the course of the
trajectory is shown. The colors represent different types of interactions:
yellow for hydrophobic contacts, red for hydrogen bond acceptors,
green for hydrogen bond donors, orange for metal interactions, dark
blue for &#x003c0;-stacking, and cyan for water bridge interactions.
The pie chart on the right shows the participation of three dominant
water molecules in one water bridge found by the interaction analysis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0003" id="gr3" position="float"/></fig><p>The analysis core is based on the Python API of <italic>PLIP</italic>(<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>) and <italic>MDAnalysis</italic>.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> This allows the calculation of interactions
within the
protein&#x02013;ligand complex and additional special ligands for each
trajectory frame. Interaction data is processed using <italic>Pandas</italic>.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> This feature enables the creation
of fingerprints that combine the most significant interactions in
each frame, allowing <italic>OpenMMDL Analysis</italic> to identify
various binding modes within the MD simulation trajectories. Furthermore,
the transition between binding modes is tracked through Markov chains,
which are generated using <italic>NetworkX</italic>.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> They show the probabilities of certain binding modes transitioning
into others. The top 10 binding modes are depicted in 2D by occurrence.
Interacting ligand atoms are highlighted with their corresponding
interaction colors, displayed in the legend (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Additionally, a PDB file is created for
a representative frame with the lowest RMSD to all other frames with
the binding mode.</p><p>Occurrence plots are generated for each unique
interaction between
a ligand moiety and a specific receptor residue. Additionally, grouped
occurrence plots for each unique interaction type formed by a portion
of the ligand are created. Each barcode section represents a distinct
frame. The presence or absence of an interaction is indicated by the
black or white color, respectively.</p><p>Point clouds, an alternative
method of interpreting interactions,
have been instrumental in studies using <italic>Dynophores</italic> (in <italic>LigandScout</italic>).<sup><xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref25">25</xref></sup><italic>OpenMMDL</italic> generates a point cloud with a single
point representing each occurrence of an interaction in a given frame.
The point&#x02019;s position is determined by the ligand moiety&#x02019;s
coordinates involved in the interaction being represented. The interaction
clouds can be viewed alongside the trajectory in a prepared <italic>Jupyter Notebook</italic> using <italic>NGLview</italic>.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup></p><p>Protein&#x02013;ligand interaction analysis
is deepened through
the characterization of water-mediated interactions and water tracing,
which examines the movement of water molecules between consecutive
frames. Additional barcodes are assigned for water-bridged interactions,
and pie charts display specific waters involved in each water bridge.
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C). Water
tracing collects water molecules showing under 1 &#x000c5; of movement
and uses Density-Based Spatial Clustering of Applications with Noise
(<italic>DBSCAN</italic>)<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> to identify
clusters of low water movement. <italic>DBSCAN</italic> is limited
by the ability to detect clusters of varying densities, and its dependence
on input parameters,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> as it is very sensitive
to changes in these parameters.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Therefore,
the distance parameter for <italic>DBSCAN</italic> can be set during
setup, with the initial chosen default set to 1 &#x000c5;. This ensures
that clusters contain only one water molecule, as water molecules
are generally at least 3 &#x000c5; apart from each other.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> As clustering occurs within a simulation with
similar parameters, the density of a desired stable water cluster
is comparable, which makes <italic>DBSCAN</italic> a suitable approach.
To ensure reasonable clustering in different experimental setups,
the clustering output comprises five folders by default, containing
clusters of different sizes (stable waters present in 25%, 50%, 75%,
90% and 99% of the simulation), allowing clusters to be sorted by
their amount of occurrence during the simulation. The clusters highlight
the regions where water molecules interact with the protein&#x02013;ligand
complex or are trapped (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). For each cluster, representative water molecules and a
list of potentially participating protein residues are retrieved.</p></sec></sec><sec id="sec3"><title>Methods</title><sec id="sec3.1"><title>Structure Preparation</title><p>Experimental structures were
obtained from RCSB PDB<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and OPM database.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> The structures were prepared using <italic>MOE
2022.02</italic>.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Missing loops were
modeled with the <italic>Loop Modeler</italic> tool, and the structures
were subsequently prepared with <italic>Structure Preparation</italic>. Chain breaks were capped with ACE and NME. The structure was protonated
using <italic>Protonate 3D</italic> at pH 7.0 and a temperature of
300 K. Nonmembrane proteins were solvated in an orthorhombic box containing
TIP3P water, 0.15 M NaCl, and 10 &#x000c5; padding. Membrane proteins
were embedded in a POPC lipid bilayer, as positioned in the OPM database,<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> with TIP3P water, 0.15 M NaCl, and a 10 &#x000c5;
padding.</p></sec><sec id="sec3.2"><title>MD Simulation</title><p>MD simulations were performed on RTX4090,
RTX3090 and RTX2080Ti GPUs (NVIDIA Corporation, Santa Clara). <italic>PDBFixer Preparation</italic> systems were simulated using the Amber
ff14SB force field,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> while <italic>AmberTools
Preparation</italic> systems utilized the Amber ff19SB force field.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Long-range electrostatic interactions were calculated
using the Particle Mesh Ewald method with a 10 &#x000c5; cutoff. The
length of all bonds involving a hydrogen atom was constrained. A Monte
Carlo barostat was applied to the system with a pressure of 1 bar
and a temperature of 300 K. The simulation was performed using Langevin
dynamics at 300 K, a friction coefficient of 1 ps<sup>&#x02013;1</sup>, and a time step of 2 fs. Ten replicas of 100 ns were generated
using an NPT ensemble and periodic boundary box conditions. The simulation
coordinates were saved every 100 ps, generating 1000 frames for each
trajectory.</p></sec><sec id="sec3.3"><title>MD Analysis</title><p>Trajectories were concatenated in <italic>VMD</italic>.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> The exceptions were the
case studies on the 5-HT<sub>2B</sub> receptor and the Ca<sub><italic>v</italic></sub>1.1 channel, which were inspected individually. This
resulted in single trajectories of 10,000 frames that were used for
analysis. The MD simulations were analyzed using <italic>OpenMMDL
Analysis</italic> with the binding mode threshold set to the default
value of 40%.</p></sec><sec id="sec3.4"><title>Coding and Writing</title><p><italic>ChatGPT</italic> [OpenAI,
L.L.C., San Francisco, CA] as well as <italic>DeepL Write</italic> [DeepL SE, Cologne, Germany] were used in the writing process for
spelling and grammar corrections. <italic>ChatGPT</italic> [OpenAI,
L.L.C., San Francisco, CA] and <italic>GitHub Copilot</italic> [GitHub
Inc., San Francisco, CA] were used for programming assistance throughout
the development of <italic>OpenMMDL</italic>.</p></sec></sec><sec id="sec4"><title>Case Studies</title><sec id="sec4.1"><title><italic>PDBFixer Preparation</italic> Case Studies</title><sec id="sec4.1.1"><title>ALK2 Kinase Bound to LDN-212854 and LDN-193189</title><p>Kinases,
such as activin-like-kinase 2 (ALK2), have great pharmaceutical relevance
due to their role in various diseases and cellular processes.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> However, high structural similarity within the
kinome renders the difficult design of kinase-specific compounds,
often leading to off-target effects. Therefore, focusing on the water
molecule network is crucial for effective drug design and structure&#x02013;activity
relationship studies.<sup><xref ref-type="bibr" rid="ref56">56</xref>&#x02212;<xref ref-type="bibr" rid="ref58">58</xref></sup> This is exemplified by the selectivity of LDN-212854
over LDN-193189 for ALK2, even though the binding modes of both compounds
within the active site of ALK2 are nearly identical.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> The nitrogen in the 5-quinoline of LDN-212854 was proposed
to form a water-mediated hydrogen bond with both K235 and E248 of
ALK2.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> LDN-193189 also interacts with
E248 via a water molecule, but this water is displaced by 1.54 &#x000c5;,
out of reach for interaction with K235.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p><p>Using <italic>OpenMMDL Analysis</italic> to analyze the ALK2-inhibitor
complexes (PDB ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3Q4U">3Q4U</ext-link> and<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> 5OXG),<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> we discovered that only LDN-212854 forms stable water clusters at
the interaction site in over 25% of the simulation (shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, left). LDN-212854
forms water bridges in 26% of the simulations, compared to the 18%
shown by LDN-189193. Pie chart visualization of water bridges indicates
that the K235 of ALK2 interacts with LDN-212854, but not LDN-193189,
in agreement with the literature.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Surprisingly,
E248 of ALK2 forms water bridges with LDN-193189 in 11.17% of MD simulations,
but not with LDN-212854, in contrast to the prediction from static
X-ray crystal structure analyses.<sup><xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref59">59</xref></sup> Instead, LDN-212854
forms a water bridge toward D354 in 25.41% of MD simulations. This
water bridge is formed by three water molecules, suggesting high stability
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, right).
Interestingly, 4-sulfamoylnaphthyl, a nanomolar ALK2 inhibitor, directly
interacts with D354 and K235.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> Its sulfonamide
group may replace the water bridge we identified between LDN-212854
and D354/K235, which strengthens the finding about the relevance of
this water bridge for ALK2 selectivity.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p><italic>OpenMMDL Analysis</italic> of simulated systems prepared
with the <italic>PDBFixer Preparation</italic>. (A) Comparison of
the BMP receptor kinase ALK2 bound to the compounds LDN-212854 (magenta)
and LDN-193189 (cyan). Simulating LDN-212854 in ALK2 resulted in three
stable water clusters at the binding site (cluster EPS: 1 &#x000c5;;
25% of 1 &#x003bc;s simulation). On the right, water bridge analysis
shows LDN-212854 forming bridges in 26% of the MD (predominantly with
D354 and K235) and LDN-193189 in 18% (with D354 and E248), with pie
charts indicating the involved water molecules. (B) Study of TLR8
binding the ligand C09: top three occurring binding modes of C09 during
a 1 &#x003bc;s MD simulation are shown. Binding mode 2 displays an additional
interaction with Y348, and binding mode 3 displays an interaction
with F405. Binding mode 4 is a transitional binding mode between binding
modes 2 and 3. (C) Interactions seen throughout one simulation replicate
(100 ns) of amlodipine in Ca<sub><italic>v</italic></sub>1.1, with
hydrophobic contacts (yellow point clouds), hydrogen bond donors (green
point clouds), and hydrogen bond acceptors (red point clouds). (D)
Binding modes 2 and 5, representing the two distinct binding modes
that LSD can occupy in the 5-HT<sub>2B</sub> receptor.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0004" id="gr4" position="float"/></fig></sec><sec id="sec4.1.2"><title>Toll-like Receptor 8 Bound to Ligand C09</title><p>Toll-like
receptors (TLRs) are a family of pattern-recognition receptors, which
are responsible for recognizing the pathogen-associated molecular
patterns (PAMPs) of bacteria, viruses, parasites and fungi. Thus,
they play an important role in the innate immune system,<sup><xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> and TLR8 agonists have been studied for their potential role in
treating cancer, asthma, viral and bacterial infections.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> We used <italic>OpenMMDL</italic> to simulate
and analyze the structure of a TLR8 agonist C09 (PDB ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3W3J">3W3J</ext-link>).<sup><xref ref-type="bibr" rid="ref63">63</xref></sup></p><p>The main interactions important for TLR8 receptor
agonism that are featured in the X-ray crystal structure of the TLR8
agonist C09 are the hydrogen bond interactions with D543 and T574
in addition to hydrophobic contacts with residues F346 Y348, Y353,
V378, I403, F405 and V573. <italic>OpenMMDL Analysis</italic> used
a binding mode threshold of 35%, which was necessary to include the
hydrogen bonding interaction with D543. The two most frequently occurring
binding modes during the simulation, binding modes 2 and 3, both exhibit
hydrogen bond interactions with D543 and Y574, and hydrophobic contacts
between the phenyl ring of C09 and the residues F405 and Y353. Binding
mode 2 features an additional hydrophobic contact between the alkyl
chain of C09 and Y348, while binding mode 3 displays a contact between
the phenyl ring and V378 instead. The third most frequent, binding
mode 4, is a transitional binding mode, which lacks both V378 and
Y348 interactions, but still exhibits interactions with Y353, F405,
D543, and T574 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). This case study demonstrates the application of OpenMMDL for
simulating multimers and showcasing ligand binding modes, including
transitional binding modes that occur during the transition between
more stable binding modes.</p></sec><sec id="sec4.1.3"><title>Voltage-Gated Calcium Channel Ca<sub><italic>v</italic></sub>1.1 Bound to Amlodipine</title><p>Voltage-gated calcium channels (Ca<sub><italic>v</italic></sub>) are membrane-bound proteins that mediate
Ca<sup>2+</sup> influx.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> The Ca<sub><italic>v</italic></sub>1.1 subtype, specifically expressed in skeletal muscles,
triggers muscle contraction upon depolarization.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></p><p>A well-studied class of Ca<sub><italic>v</italic></sub>1.1 antagonists are the 1,4-dihydropyridines (DHPs), primarily
developed for the treatment of cardiovascular diseases,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> such as nifedipine and amlodipine, both of which
have been captured in complex with Ca<sub><italic>v</italic></sub>1.1 by cryo-EM.<sup><xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref68">68</xref></sup> Both bind close to the pore of
the &#x003b1;<sub>1</sub>-subunit to a hydrogen bond between the hydroxy
oxygen of S1011 in Ca<sub><italic>v</italic></sub>1.1 and the N1-nitrogen
of the DHP-ring. Mutation of S1011 significantly reduces activity.<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> Additionally, amlodipine contains an ethanolamine
chain that extends into the Ca<sub><italic>v</italic></sub>1.1 pore
and forms a hydrogen bond to the carbonyl oxygen of S1011.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></p><p>The Ca<sub><italic>v</italic></sub>1.1
&#x003b1;<sub>1</sub>-subunit-amlodipine
complex (PDB ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="7JPX">7JPX</ext-link>) was simulated and visually inspected (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C). The protein and ligand remained in the
complex throughout all replicas. Eight out of ten replicas show the
formation of the expected hydrogen bonds between the DHP-nitrogen
and the ethanolamine chain with S1011. Among these eight replicas,
amlodipine displays an average RMSD of 2.26 &#x000c5;. However, the other
two replicas show amlodipine assuming a different binding mode without
the hydrogen bond between S1011 and the DHP-nitrogen. The RMSDs of
amlodipine in these two replicas are 3.55 and 4.10 &#x000c5;.</p></sec><sec id="sec4.1.4"><title>Serotonin Receptor 5-HT<sub>2B</sub> Bound to LSD</title><p>The
5-HT<sub>2B</sub> receptor, a member of the G-protein coupled receptor
family (GPCRs), binds the endogenous ligand serotonin. The selective
shift of the conformational equilibrium by GPCR ligand binding modulates
downstream signaling pathways mediated by arrestins and G proteins.<sup><xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref71">71</xref></sup> The three Cryo-EM structures of 5-HT<sub>2B</sub><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="7SRQ">7SRQ</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="7SRR">7SRR</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="7SRS">7SRS</ext-link>(<xref ref-type="bibr" rid="ref72">72</xref>) describe the receptor in a partially active, transducer-free
state as well as two fully active states that are G<sub><italic>q</italic></sub>-protein and &#x003b2;-arrestin-1 coupled, respectively. As arrestins
and G-proteins bind the same cytoplasmic interhelical cavity, and
their affinities depend on the phosphorylation state of the GPCR and
the presence of GTP,<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> a detailed understanding
would facilitate the development of future drugs with greater efficacy
and fewer adverse effects.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> Thus, we analyzed
possible binding modes of LSD in the transducer-free state.</p><p>We compared our results to the previously published binding mode
of LSD in 5-HT<sub>2B</sub>,<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> as well
as the X-ray crystal structure of LSD bound to 5-HT<sub>2B</sub> (PDB
ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5TVN">5TVN</ext-link>).<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> Our results indicate several possible binding
modes for LSD in 5-HT<sub>2B</sub>, two of which are depicted in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>D. The main difference
lies in the lipophilic contacts: the two ethyl groups of the diethylamide
moiety, which are freely rotatable, interact with L78<sup>3.29</sup>, W77<sup>3.28</sup>, L227<sup>7.35</sup> and V231<sup>7.39</sup>, as well as L150<sup><italic>ECL2</italic></sup>. These residues
are part of the extended binding pocket and, depending on the binding
mode, they are displayed in different combinations. This is of particular
interest since specific diethylamide configurations are proven determinants
for LSD&#x02019;s &#x003b2;-arrestin signaling profile and ligand-specific
receptor functions.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup></p><p>The salt bridge
between D81<sup>3.32</sup> and the basic nitrogen
of the ergoline ring of LSD, mandatory for the activation of aminergic
receptors, appeared in every frame of the trajectory. Additionally,
we observe a &#x003c0;-stacking aromatic interaction between the indole
moiety and F206<sup>6.51</sup>. However, the hydrogen bond between
the indole nitrogen and G162<sup>5.42</sup> is only present in 12%
of the frames. This may be due to the restrictive default settings
for hydrogen bonds in <italic>PLIP</italic>.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup></p></sec></sec><sec id="sec4.2"><title><italic>AmberTools Preparation</italic> Case Studies</title><sec id="sec4.2.1"><title>Cytochrome P450 Enzyme CYP19A1 Bound to Letrozole</title><p>Aromatase,
or CYP19A1, is a cytochrome P450 (CYP) enzyme with a crucial role
in estrogen biosynthesis.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> Aromatase has
long been a clinical target in the treatment of estrogen receptor-positive
(ER+) breast cancer, with aromatase inhibitors (AIs) being a cornerstone
in therapeutic approaches.<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> Letrozole
is a prominent third-generation nonsteroidal AI,<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> and understanding its CYP19A1 inhibition is crucial for
developing novel breast cancer treatments. We performed molecular
docking of letrozole into the binding site of aromatase to generate
a starting ligand-protein complex, paying attention to the accurate
recognition, implementation, and simulation of the special ligand <italic>Heme</italic>, which is the prosthetic group of the P450 family.
We used <italic>OpenMMDL Analysis</italic> to trace the interaction
frequency between the Heme iron and the nitrogen lone electron pair
of the triazole group throughout the MD simulations. We evaluated
the binding stability of letrozole to CYP19A1 through interaction
clouds and barcode analysis (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A). The metal-coordinating interaction feature (from
atom N7416) was present in seven of the ten distinct binding modes,
indicating a consistent interaction between letrozole and aromatase
Heme. The detected interaction features of the binding modes include
lipophilic contacts formed by the phenyl rings, mainly to neighboring
residues F90, V326, and F177. Additionally, a hydrogen bond is formed
from the nitrile group to M330 (acting as a donor) in all binding
modes.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p><italic>OpenMMDL Analysis</italic> results of systems simulated
with the <italic>AmberTools Preparation</italic>. (A) Interaction
clouds and occurrence plots for tracing the interactions between letrozole
and CYP19A1 with Heme. (B) Study of &#x003bc;-opioid receptor binding
the ligand PZM21. Ligand atom numbering of PZM21, the occurrence plots
for interactions between PZM21 and key residues in MOR over the MD
trajectories, as well as the most occurring binding mode. (C) 3D and
2D representation of FMN and interaction occurrence of &#x003c0;-stacking
and hydrophobic interactions over the course of the MD trajectory.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02158_0005" id="gr5" position="float"/></fig></sec><sec id="sec4.2.2"><title>&#x003bc;-Opioid Receptor Bound to Biased Ligand PZM21</title><p>The &#x003bc;-opioid receptor (MOR) is the primary receptor for opioid
analgesics, and therefore also their associated side effects.<sup><xref ref-type="bibr" rid="ref79">79</xref></sup> Upon activation of MOR, signaling pathways are
initiated through both G proteins and the recruitment of &#x003b2;-arrestin,
and a hypothesis gaining a lot of attention in the opioid receptor
(OR) community suggests that G-protein-biased MOR agonists may exhibit
diminished unwanted effects.<sup><xref ref-type="bibr" rid="ref80">80</xref></sup> In a study
driven by this hypothesis, computational docking followed by structure-based
optimization led to the identification of PZM21, which demonstrated
reduced side effects in mice.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> Despite
recent challenges to this hypothesis,<sup><xref ref-type="bibr" rid="ref82">82</xref>&#x02212;<xref ref-type="bibr" rid="ref84">84</xref></sup> substantial efforts
have been directed toward resolving the structures of PZM21 bound
to MOR,<sup><xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref></sup> as these structural insights provide a foundation
for understanding the structural basis of G-protein biased agonism.
This case study focused on the experimentally solved structure of
PZM21 bound to the human MOR (PDB ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="8EFO">8EFO</ext-link>)<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> as a model
to illustrate the application of <italic>OpenMMDL Setup</italic> with <italic>AmberTools Preparation</italic> for membrane-embedded system setup.
Subsequently, <italic>OpenMMDL</italic> Analysis was employed to analyze
key interactions.</p><p>The original structure, obtained from the
OPM database for proper membrane placement using <italic>PACKMOL-Memgen</italic>, was prepared after conducting structure preparation in MOE. Notably,
the dimethylamino moiety of PZM21 was recognized as charged at pH
7.4. The prepared structure was then used by the <italic>AmberTools
Preparation</italic> within <italic>OpenMMDL Setup</italic>. During <italic>OpenMMDL Analysis</italic> with default settings, challenges were
encountered in correctly converting the charged PZM21 to an SDF file
recognizable by <italic>OpenMMDL Analysis</italic> using <italic>OpenBabel</italic>. An SDF file of PZM21 was prepared in <italic>MOE</italic> instead
and then specified using the &#x02018;-l&#x02019; flag in <italic>OpenMMDL
Analysis</italic>. To ensure accurate residue numbering adhering to
the Ballesteros&#x02013;Weinstein system, the &#x02018;-ref&#x02019;
flag was employed to align the residue numbers in the output topology
file of the MD simulation with the reference protein.</p><p>Throughout
the trajectory, the positive nitrogen of PZM21 maintained
a persistent polar interaction with D149<sup>3.32</sup> (100.00% of
the MD trajectory) (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B, lower left). This interaction is universally observed in
opioid receptors and is crucial for MOR activation.<sup><xref ref-type="bibr" rid="ref87">87</xref>&#x02212;<xref ref-type="bibr" rid="ref90">90</xref></sup> The phenolic moiety of PZM21
that is initially oriented toward transmembrane helix 5 (TM5) in the
starting structure gradually shifted to form a hydrogen bond with
H299<sup>6.52</sup> (98.80%) (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B, upper right). This interaction is crucial for both
G protein and &#x003b2;-arrestin signaling activities.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> The thiophene moiety of PZM21 exhibits hydrophobic contacts
similar to those seen with neutral agonists including fentanyl.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> However, it is noteworthy that these interactions
occurred less frequently during the MD simulation (V145<sup>3.28</sup> - 6.21%, I146<sup>3.29</sup> - 32.46%) (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B, middle left). PZM21 is hypothesized to
exhibit reduced arrestin activity because it forms fewer interactions
with TM6/7. Specifically, it lacks close contacts with W295<sup>6.48</sup>, G327<sup>7.42</sup>, and Y328<sup>7.43</sup>, compared to TRV130.
Despite being a biased agonist, TRV130 still has weak arrestin activity.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> The occurrence plots of the benzene ring of
the phenol moiety show either no or very low frequencies of the aforementioned
interactions during the MD trajectory, supporting the hypothesis regarding
the interaction feature pattern TM6/7. The most common binding mode
13, displays all necessary interactions for the G-biased agonism of
PZM21 (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B, lower
right).</p></sec><sec id="sec4.2.3"><title>FMN-Riboswitch Bound to Flavin Mononucleotide</title><p>Riboswitches
are regulatory elements found in mRNA (mRNA) that sense various metabolites
and ions to regulate gene expression. Flavin mononucleotide (FMN)
riboswitches are a promising target for broad-spectrum antibacterial
drug development due to their prevalence in a wide range of bacterial
species.<sup><xref ref-type="bibr" rid="ref91">91</xref>&#x02212;<xref ref-type="bibr" rid="ref94">94</xref></sup> We used the X-ray crystal structure of the FMN riboswitch bound
to FMN (PDB ID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3F2Q">3F2Q</ext-link>)<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> to demonstrate the competence of OpenMMDL
in simulating and analyzing RNA-ligand complexes (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>C). The system was prepared
by deleting the modified triphosphate tips of the two RNA chains and
protonating the system with Protonate3D in <italic>MOE</italic>. The
cocrystallized ions were retained, especially magnesium ions, which
have been shown to stabilize RNA structures.<sup><xref ref-type="bibr" rid="ref96">96</xref></sup> The <italic>AmberTools Preparation</italic> enabled easy application
of suitable AMBER force field parameters to each part of our system.</p><p><italic>OpenMMDL Analysis</italic> enables us to monitor the key
interactions of ligands with RNA receptors using the &#x0201c;-nuc
True&#x0201d; flag. Since nucleic acids are highly polar systems, ligand
binding is strongly directed by hydrogen bond interactions. In the
case of FMN, we observe an abundance of hydrogen bonds being formed
throughout the MD trajectory. Additionally, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>C shows the &#x003c0;-stacking interactions
between the nucleic acid bases and FMN, which further strengthen the
binding of the ligand to RNA molecules; the RNA bases are stacked
neatly upon each other, allowing for a significant energy gain when
a ligand intercalates between them. However, the occurrence of &#x003c0;-stacking
in the analysis is less frequent than expected. This may be due to
insufficient interaction recognition through <italic>PLIP</italic>(<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>) in some cases. To improve the recognition of specific
interactions, manual editing of the tolerances in the <italic>PLIP</italic>(<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>) configuration files may be necessary. However, in
this case, we did not edit the recognition thresholds in order to
maintain the reproducibility of the results. Finally, we identified
hydrophobic contacts with the RNA, as shown in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>C. It is uncommon for polar nucleic acids
to form these contacts, yet information on these rare interaction
features could prove invaluable in the design of novel ligands.</p></sec></sec></sec><sec id="sec5"><title>Discussion</title><p>Despite <italic>OpenMMDL</italic>&#x02019;s
versatility, discussing
its limitations is crucial for further development and usage. While
the integration of <italic>PDBFixer</italic> provides basic functionalities
for protein cleanup, it may have difficulty handling cocrystallized
ligands. To address this, it is recommended to use modeling tools
such as <italic>MOE</italic>(<xref ref-type="bibr" rid="ref52">52</xref>) or <italic>Maestro</italic>.<sup><xref ref-type="bibr" rid="ref97">97</xref></sup><italic>OpenMMDL</italic> cannot construct systems with covalently bound ligands, as these
rely on the GAFF force field<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> along with
expertise and careful validation of the user. However, <italic>OpenMMDL</italic> allows for the inclusion of special ligands incompatible with GAFF,
such as the Heme in the CYP19A1 case study, via the <italic>Amber
parameter database</italic>.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup></p><p>During <italic>PDBFixer Preparation</italic>, users can provide
ligand input in SDF or MOL2 format. The SDF format is recommended,
with manual review prior to input to ensure chemically accurate structures,
including proper assignment of bond orders for aromatic rings. Optionally, <italic>RDKit</italic>(<xref ref-type="bibr" rid="ref10">10</xref>) can be used in this step
for ligand minimization and sanitization, performing checks such as
valence validation, aromaticity detection, conjugation, and hybridization
assignment. Problems can arise in this automated process with nonstandard
ligands, such as those with delocalized charges or unusual valence
patterns. For example, we encountered a compound with a thiophene
moiety that could not be sanitized, likely due to a failure to assign
double bonds to the aromatic ring. It is also reported that some ligands
with improper valences, such as a nitrogen atom with four bonds that
lacks a formal positive charge, and some ligands with atoms with specific
bonds to a metal ion, lead to sanitization errors in <italic>RDKit</italic>.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> In the latter case, an alternative
approach is to use the <italic>AmberTools Preparation</italic> in
the <italic>OpenMMDL Setup</italic>, where the nonstandard ligand
can be properly prepared using the Amber Parameter Database. Careful
evaluation of the simulation system&#x02019;s PDB file and the final
trajectories is crucial to ensure accurate representation and behavior.</p><p>Selecting water and membrane parameters with <italic>PDBFixer</italic> may result in inconsistencies in the number of water atoms across
different system builds, although identical atoms in each replica
are necessary for post-MD analysis. Fortunately, <italic>AmberTools
Preparation</italic> provides a reliable solution to address the problem
of atom inconsistency through <italic>PACKMOL-Memgen</italic>, for
which it is necessary to align the entire structure with the corresponding
OPM structure.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>The standardized
MD protocol provided by <italic>OpenMMDL</italic> covers minimization,
equilibration, and production runs, but experienced
users should customize the protocols to their specific needs.</p><p><italic>OpenMMDL</italic> can be used to postprocess MD trajectories
for analysis with <italic>MDTraj</italic>(<xref ref-type="bibr" rid="ref16">16</xref>) and <italic>MDAnalysis</italic>.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> However,
these tools may encounter difficulties when handling systems with
more than 9999 atoms. In cases such as the Ca<sub><italic>v</italic></sub>1.1 ion channel, which features a large membrane, the solution
has been to remove the membrane and water components to enable postprocessing
within this constraint. To this end, <italic>OpenMMDL Analysis</italic> offers a useful postprocessing function: residue renumbering. This
is necessary because when the original protein PDB file is input into <italic>AmberTools</italic> or <italic>PDBFixer</italic>, the residue numbering
restarts from 1, leading to inconsistencies between the original PDB
file and the output system. Maintaining the original residue numbering
is crucial for accurately identifying interactions with specific residues,
especially in the case of GPCRs such as 5-HT<sub>2B</sub> and MOR,
which follow the Ballesteros-Weinstein numbering convention.<sup><xref ref-type="bibr" rid="ref98">98</xref></sup> To address this issue, OpenMMDL Analysis provides
the &#x02018;-ref&#x02019; flag, which aligns residue numbers in the
output topology file with the reference protein.</p><p>When creating
2D representations of molecular interactions using <italic>RDKit</italic>(<xref ref-type="bibr" rid="ref10">10</xref>) in postprocessing, it
is important to exercise caution. <italic>OpenMMDL Analysis</italic> can automatically generate a ligand SDF file from the system&#x02019;s
topology file using <italic>OpenBabel</italic>.<sup><xref ref-type="bibr" rid="ref99">99</xref></sup> However, as shown in the MOR case study with PZM21, this
method may not always produce an SDF file that can be recognized by <italic>RDKit</italic>,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> which could result in
errors. Therefore, using the &#x02018;-l&#x02019; flag and providing
an SDF file for the ligand that was prepared beforehand is recommended.</p><p><italic>OpenMMDL Analysis</italic> provides time series interaction
analysis in the form of bar codes and point cloud visualization. These
techniques draw on the methodology initially outlined by the <italic>Dynophore App</italic>(<xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref25">25</xref>) tool, built upon the <italic>LigandScout</italic>(<xref ref-type="bibr" rid="ref26">26</xref>) structure-based 3D pharmacophore generation algorithm.
This representation allows users to visualize interactions throughout
the simulation. One current drawback in the <italic>OpenMMDL Analysis</italic> implementation concerns the underlying interaction identification
algorithm. <italic>OpenMMDL Analysis</italic> uses <italic>PLIP</italic>,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> which sees less utilization compared to
the <italic>LigandScout</italic>(<xref ref-type="bibr" rid="ref26">26</xref>) 3D pharmacophore
generation algorithm, due to issues such as the &#x003c0;-stacking example
in the FMN case study. <italic>OpenMMDL Analysis</italic> offers an
advantage over <italic>Dynophore App</italic> in its current state,
due to being free for use and open-source.</p></sec><sec id="sec6"><title>Conclusion</title><p>This study presents <italic>OpenMMDL</italic>, an open-source tool
for preparing protein&#x02013;ligand complexes for MD simulations using <italic>OpenMMDL Setup</italic>, performing these MD simulations with <italic>OpenMM</italic> through <italic>OpenMMDL Simulation</italic>, and
analyzing the MD simulation trajectories to display the protein&#x02013;ligand
interactions and stable waters with <italic>OpenMMDL Analysis</italic>. The tool offers low-code users a straightforward way to access
and fully use MD simulations. <italic>OpenMMDL</italic> was applied
to various pharmaceutical drug targets, demonstrating its potential
applications in modern drug discovery.</p></sec><sec sec-type="data-availability" id="sec10"><title>Data and Software Availability</title><p>OpenMMDL is open-source,
and the code is freely available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/wolberlab/OpenMMDL">https://github.com/wolberlab/OpenMMDL</uri>. Documentation and tutorials for OpenMMDL are available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://openmmdl.readthedocs.io">https://openmmdl.readthedocs.io</uri>.</p></sec></body><back><notes notes-type="" id="notes1"><title>Author Contributions</title><p><sup>&#x02207;</sup> V.T., Y.C., N.P.D., and L.O. contributed equally to this work.
The manuscript was written through the contributions of all authors.
V.T., Y.C., N.P.D., and L.O. designed the software. All authors contributed
to the design, execution, and analysis of experiments. G.W. directed
the studies. All authors have approved the final version of the manuscript.</p></notes><notes notes-type="funding-statement" id="notes3"><p>N.P.D.
was funded
by the Deutsche Forschungsgemeinschaft (grant number DFG 435233773).
L.O. was funded by the International Max Planck Research School IMPRS-Biology
and Computation (IMPRS-BAC). T.N. was funded by the Sonnenfeld Stiftung.
Y.C. was funded by the China Scholarship Council (CSC). S.L. was funded
by the China Scholarship Council (CSC). M.B. was funded by the Friedrich
Naumann Foundation (FNF). P.K. received funding by the Deutsche Forschungsgemeinschaft
Sonderforschungsbereich-1444 (DFG-SFB1444).</p></notes><notes notes-type="COI-statement" id="notes4"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors thank the <italic>OpenMM Toolkit</italic> creators and <italic>Dynophore</italic> contributors, especially
John Chodera, Peter Eastman, Mike Henry, and the whole Chodera Lab
for their work on <italic>OpenMM</italic> and <italic>OpenMM Setup</italic>, which heavily influenced <italic>OpenMMDL Setup</italic> and the
whole workflow. We also thank our former co-workers David Schaller
and Dominique Sydow for inspiring the <italic>OpenMMDL Simulation</italic> and <italic>OpenMMDL Analysis</italic> parts of the workflow, through
their work on <italic>TeachOpenCADD</italic> in the Volkamer lab.
The authors would like to thank all of the creators of the open-source
packages applied in this project, especially the creators and contributors
of <italic>PLIP</italic>, <italic>RDKit</italic>, and <italic>MDAnalysis</italic>, which are used in <italic>OpenMMDL</italic>. We would like to thank
our open-source contributors Marvin Taterra and Armenia Napoli for
their involvement in <italic>OpenMMDL</italic>.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Bermudez</surname><given-names>M.</given-names></name>; <name><surname>Mortier</surname><given-names>J.</given-names></name>; <name><surname>Rakers</surname><given-names>C.</given-names></name>; <name><surname>Sydow</surname><given-names>D.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>
<article-title>More than
a Look into a Crystal Ball: Protein Structure Elucidation Guided by
Molecular Dynamics Simulations</article-title>. <source>Drug Discovery
Today</source>
<year>2016</year>, <volume>21</volume>, <fpage>1799</fpage>&#x02013;<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2016.07.001</pub-id>.<pub-id pub-id-type="pmid">27417339</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Rakers</surname><given-names>C.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>; <name><surname>Keller</surname><given-names>B. G.</given-names></name>; <name><surname>Mortier</surname><given-names>J.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>
<article-title>Computational
Close up on Protein-Protein Interactions: How to Unravel the Invisible
Using Molecular Dynamics Simulations?</article-title>. <source>Wiley
Interdiscip. Rev. Comput. Mol. Sci.</source>
<year>2015</year>, <volume>5</volume>, <fpage>345</fpage>&#x02013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1002/wcms.1222</pub-id>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Mortier</surname><given-names>J.</given-names></name>; <name><surname>Rakers</surname><given-names>C.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>; <name><surname>Murgueitio</surname><given-names>M. S.</given-names></name>; <name><surname>Riniker</surname><given-names>S.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>
<article-title>The Impact of Molecular
Dynamics
on Drug Design: Applications for the Characterization of Ligand-Macromolecule
Complexes</article-title>. <source>Drug Discovery Today</source>
<year>2015</year>, <volume>20</volume>, <fpage>686</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2015.01.003</pub-id>.<pub-id pub-id-type="pmid">25615716</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Case</surname><given-names>D. A.</given-names></name>; et al. <article-title>AmberTools</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2023</year>, <volume>63</volume>, <fpage>6183</fpage>&#x02013;<lpage>6191</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.3c01153</pub-id>.<pub-id pub-id-type="pmid">37805934</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Abraham</surname><given-names>M. J.</given-names></name>; <name><surname>Murtola</surname><given-names>T.</given-names></name>; <name><surname>Schulz</surname><given-names>R.</given-names></name>; <name><surname>P&#x000e1;ll</surname><given-names>S.</given-names></name>; <name><surname>Smith</surname><given-names>J. C.</given-names></name>; <name><surname>Hess</surname><given-names>B.</given-names></name>; <name><surname>Lindahl</surname><given-names>E.</given-names></name>
<article-title>GROMACS: High Performance
Molecular Simulations through Multi-Level Parallelism from Laptops
to Supercomputers</article-title>. <source>SoftwareX</source>
<year>2015</year>, <volume>1</volume>, <fpage>19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Brooks</surname><given-names>B. R.</given-names></name>; et al. <article-title>CHARMM: The Biomolecular
Simulation Program</article-title>. <source>J. Comput. Chem.</source>
<year>2009</year>, <volume>30</volume>, <fpage>1545</fpage>&#x02013;<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21287</pub-id>.<pub-id pub-id-type="pmid">19444816</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Phillips</surname><given-names>J. C.</given-names></name>; et al. <article-title>Scalable Molecular Dynamics
on CPU and GPU Architectures with NAMD</article-title>. <source>J. Chem.
Phys.</source>
<year>2020</year>, <volume>153</volume> (<issue>4</issue>), <fpage>044130</fpage><pub-id pub-id-type="doi">10.1063/5.0014475</pub-id>.<pub-id pub-id-type="pmid">32752662</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="conf-proc" id="cit8"><person-group person-group-type="allauthors"><name><surname>Bowers</surname><given-names>K. J.</given-names></name>; <name><surname>Chow</surname><given-names>E.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>Dror</surname><given-names>R. O.</given-names></name>; <name><surname>Eastwood</surname><given-names>M. P.</given-names></name>; <name><surname>Gregersen</surname><given-names>B. A.</given-names></name>; <name><surname>Klepeis</surname><given-names>J. L.</given-names></name>; <name><surname>Kolossvary</surname><given-names>I.</given-names></name>; <name><surname>Moraes</surname><given-names>M. A.</given-names></name>; <name><surname>Sacerdoti</surname><given-names>F. D.</given-names></name>; <name><surname>Salmon</surname><given-names>J. K.</given-names></name>; <name><surname>Shan</surname><given-names>Y.</given-names></name>; <name><surname>Shaw</surname><given-names>D.
E.</given-names></name></person-group><article-title>Scalable Algorithms
for Molecular
Dynamics Simulations on Commodity Clusters</article-title>. In <source>Proceedings of the 2006 ACM/IEEE Conference on Supercomputing</source>; <publisher-name>Association for Computing Machinery</publisher-name>, <year>2006</year>; p <fpage>84</fpage>. <pub-id pub-id-type="doi">10.1145/1188455.1188544</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Eastman</surname><given-names>P.</given-names></name>; <name><surname>Swails</surname><given-names>J.</given-names></name>; <name><surname>Chodera</surname><given-names>J. D.</given-names></name>; <name><surname>McGibbon</surname><given-names>R. T.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Beauchamp</surname><given-names>K. A.</given-names></name>; <name><surname>Wang</surname><given-names>L.-P.</given-names></name>; <name><surname>Simmonett</surname><given-names>A. C.</given-names></name>; <name><surname>Harrigan</surname><given-names>M. P.</given-names></name>; <name><surname>Stern</surname><given-names>C. D.</given-names></name>; <name><surname>Wiewiora</surname><given-names>R. P.</given-names></name>; <name><surname>Brooks</surname><given-names>B. R.</given-names></name>; <name><surname>Pande</surname><given-names>V. S.</given-names></name>
<article-title>OpenMM 7: Rapid
Development of High Performance Algorithms
for Molecular Dynamics</article-title>. <source>PLoS Comput. Biol.</source>
<year>2017</year>, <volume>13</volume>, <elocation-id>e1005659</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005659</pub-id>.<pub-id pub-id-type="pmid">28746339</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="weblink" id="cit10"><person-group person-group-type="allauthors"><name><surname>Landrum</surname><given-names>G.</given-names></name></person-group><article-title>RDKit: Open-Source
Cheminformatics Software</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.rdkit.org">https://www.rdkit.org</uri> (accessed
2024-11-01).</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Sydow</surname><given-names>D.</given-names></name>; <name><surname>Rodr&#x000ed;guez-Guerra</surname><given-names>J.</given-names></name>; <name><surname>Kimber</surname><given-names>T. B.</given-names></name>; <name><surname>Schaller</surname><given-names>D.</given-names></name>; <name><surname>Taylor</surname><given-names>C. J.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Leja</surname><given-names>M.</given-names></name>; <name><surname>Misra</surname><given-names>S.</given-names></name>; <name><surname>Wichmann</surname><given-names>M.</given-names></name>; <name><surname>Ariamajd</surname><given-names>A.</given-names></name>; <name><surname>Volkamer</surname><given-names>A.</given-names></name>
<article-title>TeachOpenCADD 2022:
open source and FAIR Python Pipelines to Assist in Structural Bioinformatics
and Cheminformatics Research</article-title>. <source>Nucleic Acids
Res.</source>
<year>2022</year>, <volume>50</volume>, <fpage>W753</fpage>&#x02013;<lpage>W760</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac267</pub-id>.<pub-id pub-id-type="pmid">35524571</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="weblink" id="cit12"><person-group person-group-type="allauthors"><name><surname>Eastman</surname><given-names>P.</given-names></name></person-group><article-title>Openmm-Setup</article-title>. <year>2023</year>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/openmm/openmm-setup">https://github.com/openmm/openmm-setup</uri> (accessed 2024-11-01).</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Humphrey</surname><given-names>W.</given-names></name>; <name><surname>Dalke</surname><given-names>A.</given-names></name>; <name><surname>Schulten</surname><given-names>K.</given-names></name>
<article-title>VMD: Visual Molecular
Dynamics</article-title>. <source>J. Mol. Graph.</source>
<year>1996</year>, <volume>14</volume>, <fpage>33</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id>.<pub-id pub-id-type="pmid">8744570</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Grant</surname><given-names>B.</given-names></name>; <name><surname>Rodrigues</surname><given-names>A.</given-names></name>; <name><surname>ElSawy</surname><given-names>K.</given-names></name>; <name><surname>McCammon</surname><given-names>J.</given-names></name>; <name><surname>Caves</surname><given-names>L.</given-names></name>
<article-title>Bio3D: An
R package for the Comparative Analysis of Protein structures</article-title>. <source>Bioinformatics</source>
<year>2006</year>, <volume>22</volume>, <fpage>2695</fpage>&#x02013;<lpage>2696</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl461</pub-id>.<pub-id pub-id-type="pmid">16940322</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Michaud-Agrawal</surname><given-names>N.</given-names></name>; <name><surname>Denning</surname><given-names>E. J.</given-names></name>; <name><surname>Woolf</surname><given-names>T. B.</given-names></name>; <name><surname>Beckstein</surname><given-names>O.</given-names></name>
<article-title>MDAnalysis:
a Toolkit for the Analysis of Molecular Dynamics Simulations</article-title>. <source>J. Comput. Chem.</source>
<year>2011</year>, <volume>32</volume>, <fpage>2319</fpage>&#x02013;<lpage>2327</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21787</pub-id>.<pub-id pub-id-type="pmid">21500218</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>McGibbon</surname><given-names>R. T.</given-names></name>; <name><surname>Beauchamp</surname><given-names>K. A.</given-names></name>; <name><surname>Harrigan</surname><given-names>M. P.</given-names></name>; <name><surname>Klein</surname><given-names>C.</given-names></name>; <name><surname>Swails</surname><given-names>J. M.</given-names></name>; <name><surname>Hern&#x000e1;ndez</surname><given-names>C. X.</given-names></name>; <name><surname>Schwantes</surname><given-names>C. R.</given-names></name>; <name><surname>Wang</surname><given-names>L.-P.</given-names></name>; <name><surname>Lane</surname><given-names>T. J.</given-names></name>; <name><surname>Pande</surname><given-names>V. S.</given-names></name>
<article-title>MDTraj: a Modern Open Library for the Analysis of Molecular
Dynamics Trajectories</article-title>. <source>Biophys. J.</source>
<year>2015</year>, <volume>109</volume>, <fpage>1528</fpage>&#x02013;<lpage>1532</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2015.08.015</pub-id>.<pub-id pub-id-type="pmid">26488642</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Doerr</surname><given-names>S.</given-names></name>; <name><surname>Harvey</surname><given-names>M. J.</given-names></name>; <name><surname>No&#x000e9;</surname><given-names>F.</given-names></name>; <name><surname>De Fabritiis</surname><given-names>G.</given-names></name>
<article-title>HTMD: High-Throughput
Molecular Dynamics for Molecular Discovery</article-title>. <source>J. Chem. Theory Comput.</source>
<year>2016</year>, <volume>12</volume>, <fpage>1845</fpage>&#x02013;<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.6b00049</pub-id>.<pub-id pub-id-type="pmid">26949976</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Adasme</surname><given-names>M. F.</given-names></name>; <name><surname>Linnemann</surname><given-names>K. L.</given-names></name>; <name><surname>Bolz</surname><given-names>S. N.</given-names></name>; <name><surname>Kaiser</surname><given-names>F.</given-names></name>; <name><surname>Salentin</surname><given-names>S.</given-names></name>; <name><surname>Haupt</surname><given-names>V. J.</given-names></name>; <name><surname>Schroeder</surname><given-names>M.</given-names></name>
<article-title>PLIP 2021:
Expanding the Scope of
the Protein-Ligand Interaction Profiler to DNA and RNA</article-title>. <source>Nucleic Acids Res.</source>
<year>2021</year>, <volume>49</volume>, <fpage>W530</fpage>&#x02013;<lpage>W534</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab294</pub-id>.<pub-id pub-id-type="pmid">33950214</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Salentin</surname><given-names>S.</given-names></name>; <name><surname>Schreiber</surname><given-names>S.</given-names></name>; <name><surname>Haupt</surname><given-names>V. J.</given-names></name>; <name><surname>Adasme</surname><given-names>M. F.</given-names></name>; <name><surname>Schroeder</surname><given-names>M.</given-names></name>
<article-title>PLIP: Fully
Automated Protein&#x02013;Ligand Interaction Profiler</article-title>. <source>Nucleic Acids Res.</source>
<year>2015</year>, <volume>43</volume>, <fpage>W443</fpage>&#x02013;<lpage>W447</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv315</pub-id>.<pub-id pub-id-type="pmid">25873628</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Wunsch</surname><given-names>F.</given-names></name>; <name><surname>Nguyen</surname><given-names>T. N.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>
<article-title>Structural Determinants
of Sphingosine-1-Phosphate Receptor Selectivity</article-title>. <source>Arch. Pharm.</source>
<year>2023</year>, <volume>356</volume>, <fpage>2300387</fpage><pub-id pub-id-type="doi">10.1002/ardp.202300387</pub-id>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Puls</surname><given-names>K.</given-names></name>; <name><surname>Schmidhammer</surname><given-names>H.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Spetea</surname><given-names>M.</given-names></name>
<article-title>Mechanistic Characterization
of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid
Analgesic, at the Mu-, Delta-, Kappa-Opioid and Nociceptin Receptors</article-title>. <source>Molecules</source>
<year>2022</year>, <volume>27</volume>, <fpage>919</fpage><pub-id pub-id-type="doi">10.3390/molecules27030919</pub-id>.<pub-id pub-id-type="pmid">35164182</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Schaller</surname><given-names>D.</given-names></name>; <name><surname>&#x00160;ribar</surname><given-names>D.</given-names></name>; <name><surname>Noonan</surname><given-names>T.</given-names></name>; <name><surname>Deng</surname><given-names>L.</given-names></name>; <name><surname>Nguyen</surname><given-names>T. N.</given-names></name>; <name><surname>Pach</surname><given-names>S.</given-names></name>; <name><surname>Machalz</surname><given-names>D.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>
<article-title>Next Generation
3D Pharmacophore Modeling</article-title>. <source>Wiley Interdiscip.
Rev. Comput. Mol. Sci.</source>
<year>2020</year>, <volume>10</volume>, <elocation-id>e1468</elocation-id><pub-id pub-id-type="doi">10.1002/wcms.1468</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="thesis" id="cit23"><person-group person-group-type="allauthors"><name><surname>Sydow</surname><given-names>D.</given-names></name></person-group><article-title>Dynophores: Novel
Dynamic Pharmacophores</article-title>. Master&#x02019;s Thesis, <publisher-name>Humboldt-Universit&#x000e4;t zu Berlin, Lebenswissenschaftliche Fakult&#x000e4;t</publisher-name>, <year>2015</year>. <pub-id pub-id-type="doi">10.18452/14267</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Bock</surname><given-names>A.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>; <name><surname>Krebs</surname><given-names>F.</given-names></name>; <name><surname>Matera</surname><given-names>C.</given-names></name>; <name><surname>Chirinda</surname><given-names>B.</given-names></name>; <name><surname>Sydow</surname><given-names>D.</given-names></name>; <name><surname>Dallanoce</surname><given-names>C.</given-names></name>; <name><surname>Holzgrabe</surname><given-names>U.</given-names></name>; <name><surname>De Amici</surname><given-names>M.</given-names></name>; <name><surname>Lohse</surname><given-names>M. J.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Mohr</surname><given-names>K.</given-names></name>
<article-title>Ligand Binding
Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled
Receptor</article-title>. <source>J. Biol. Chem.</source>
<year>2016</year>, <volume>291</volume>, <fpage>16375</fpage>&#x02013;<lpage>16389</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.735431</pub-id>.<pub-id pub-id-type="pmid">27298318</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="weblink" id="cit25"><person-group person-group-type="allauthors"><name><surname>Sydow</surname><given-names>D.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name></person-group><article-title>dynophores</article-title>. <year>2024</year>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/wolberlab/dynophores">https://github.com/wolberlab/dynophores</uri> (accessed 2024-10-28).</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Langer</surname><given-names>T.</given-names></name>
<article-title>LigandScout: 3-D Pharmacophores
Derived from Protein-Bound
Ligands and Their Use as Virtual Screening Filters</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2005</year>, <volume>45</volume>, <fpage>160</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1021/ci049885e</pub-id>.<pub-id pub-id-type="pmid">15667141</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Bouysset</surname><given-names>C.</given-names></name>; <name><surname>Fiorucci</surname><given-names>S.</given-names></name>
<article-title>ProLIF: A Library to Encode Molecular Interactions
as Fingerprints</article-title>. <source>J. Cheminform.</source>
<year>2021</year>, <volume>13</volume>, <fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s13321-021-00548-6</pub-id>.<pub-id pub-id-type="pmid">34563256</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="weblink" id="cit28"><article-title>SMARTS - A Language for Describing Molecular Patterns</article-title>. <publisher-name>Daylight Chemical Information Systems, Inc.</publisher-name>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.daylight.com/dayhtml/doc/theory/theory.smarts.html">https://www.daylight.com/dayhtml/doc/theory/theory.smarts.html</uri> (accessed 2024-11-01).</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Young</surname><given-names>T.</given-names></name>; <name><surname>Abel</surname><given-names>R.</given-names></name>; <name><surname>Kim</surname><given-names>B.</given-names></name>; <name><surname>Berne</surname><given-names>B. J.</given-names></name>; <name><surname>Friesner</surname><given-names>R. A.</given-names></name>
<article-title>Motifs
for Molecular Recognition Exploiting Hydrophobic Enclosure in Protein&#x02013;Ligand
Binding</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<year>2007</year>, <volume>104</volume>, <fpage>808</fpage>&#x02013;<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0610202104</pub-id>.<pub-id pub-id-type="pmid">17204562</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="book" id="cit30"><person-group person-group-type="allauthors"><name><surname>Grinberg</surname><given-names>M.</given-names></name></person-group> In <source>Flask Web Development:
developing web applications with python</source>; <publisher-name>O&#x02019;Reilly Media, Inc.</publisher-name>, <year>2018</year>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Kollman</surname><given-names>P. A.</given-names></name>; <name><surname>Case</surname><given-names>D. A.</given-names></name>
<article-title>Automatic
Atom Type
and Bond Type Perception in Molecular Mechanical Calculations</article-title>. <source>J. Mol. Graph. Model.</source>
<year>2006</year>, <volume>25</volume>, <fpage>247</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2005.12.005</pub-id>.<pub-id pub-id-type="pmid">16458552</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wolf</surname><given-names>R. M.</given-names></name>; <name><surname>Caldwell</surname><given-names>J. W.</given-names></name>; <name><surname>Kollman</surname><given-names>P. A.</given-names></name>; <name><surname>Case</surname><given-names>D. A.</given-names></name>
<article-title>Development
and Testing of a General Amber Force Field</article-title>. <source>J. Comput. Chem.</source>
<year>2004</year>, <volume>25</volume>, <fpage>1157</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id>.<pub-id pub-id-type="pmid">15116359</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="weblink" id="cit33"><article-title>AMBER Parameter Database</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://amber.manchester.ac.uk/">http://amber.manchester.ac.uk/</uri> (accessed 2024-10-28).</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Schott-Verdugo</surname><given-names>S.</given-names></name>; <name><surname>Gohlke</surname><given-names>H.</given-names></name>
<article-title>PACKMOL-Memgen:
A Simple-To-Use, Generalized Workflow
for Membrane-Protein-Lipid-Bilayer System Building</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2019</year>, <volume>59</volume>, <fpage>2522</fpage>&#x02013;<lpage>2528</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00269</pub-id>.<pub-id pub-id-type="pmid">31120747</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>
<article-title>Merck Molecular
Force Field. I. Basis, Form, Scope, Parameterization, and Performance
of MMFF94</article-title>. <source>J. Comput. Chem.</source>
<year>1996</year>, <volume>17</volume>, <fpage>490</fpage>&#x02013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;490::AID-JCC1&#x0003e;3.0.CO;2-P</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>
<article-title>Merck Molecular
Force Field. II. MMFF94 van der Waals and Electrostatic Parameters
for Intermolecular Interactions</article-title>. <source>J. Comput.
Chem.</source>
<year>1996</year>, <volume>17</volume>, <fpage>520</fpage>&#x02013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;520::AID-JCC2&#x0003e;3.0.CO;2-W</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>
<article-title>Merck Molecular
Force Field. III. Molecular Geometries and Vibrational Frequencies
for MMFF94</article-title>. <source>J. Comput. Chem.</source>
<year>1996</year>, <volume>17</volume>, <fpage>553</fpage>&#x02013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;553::AID-JCC3&#x0003e;3.0.CO;2-T</pub-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>; <name><surname>Nachbar</surname><given-names>R. B.</given-names></name>
<article-title>Merck Molecular
Force Field. IV. Conformational Energies
and Geometries for MMFF94</article-title>. <source>J. Comput. Chem.</source>
<year>1996</year>, <volume>17</volume>, <fpage>587</fpage>&#x02013;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;587::AID-JCC4&#x0003e;3.0.CO;2-Q</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>; <name><surname>Merck Molecular Force
Field</surname><given-names>V.</given-names></name>
<article-title>Extension of MMFF94 Using Experimental
Data, Additional Computational Data, and Empirical Rules</article-title>. <source>J. Comput. Chem.</source>
<year>1996</year>, <volume>17</volume>, <fpage>616</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;616::AID-JCC5&#x0003e;3.0.CO;2-X</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>
<article-title>MMFF VI.
MMFF94s Option for Energy Minimization Studies</article-title>. <source>J. Comput. Chem.</source>
<year>1999</year>, <volume>20</volume>, <fpage>720</fpage>&#x02013;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199905)20:7&#x0003c;720::AID-JCC7&#x0003e;3.0.CO;2-X</pub-id>.<pub-id pub-id-type="pmid">34376030</pub-id>
</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Halgren</surname><given-names>T. A.</given-names></name>; <name><surname>MMFF</surname><given-names>V. I. I.</given-names></name>
<article-title>Characterization
of MMFF94, MMFF94s, and Other Widely
Available Force Fields for Conformational Energies and for Intermolecular-Interaction
Energies and Geometries</article-title>. <source>J. Comput. Chem.</source>
<year>1999</year>, <volume>20</volume>, <fpage>730</fpage>&#x02013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199905)20:7&#x0003c;730::AID-JCC8&#x0003e;3.0.CO;2-T</pub-id>.<pub-id pub-id-type="pmid">34376036</pub-id>
</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Mobley</surname><given-names>D. L.</given-names></name>; <name><surname>Bannan</surname><given-names>C. C.</given-names></name>; <name><surname>Rizzi</surname><given-names>A.</given-names></name>; <name><surname>Bayly</surname><given-names>C. I.</given-names></name>; <name><surname>Chodera</surname><given-names>J. D.</given-names></name>; <name><surname>Lim</surname><given-names>V. T.</given-names></name>; <name><surname>Lim</surname><given-names>N. M.</given-names></name>; <name><surname>Beauchamp</surname><given-names>K. A.</given-names></name>; <name><surname>Slochower</surname><given-names>D. R.</given-names></name>; <name><surname>Shirts</surname><given-names>M. R.</given-names></name>; <name><surname>Gilson</surname><given-names>M. K.</given-names></name>; <name><surname>Eastman</surname><given-names>P. K.</given-names></name>
<article-title>Escaping
Atom Types in Force Fields Using Direct Chemical Perception</article-title>. <source>J. Chem. Theory Comput.</source>
<year>2018</year>, <volume>14</volume>, <fpage>6076</fpage>&#x02013;<lpage>6092</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.8b00640</pub-id>.<pub-id pub-id-type="pmid">30351006</pub-id>
</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="computer-program" id="cit43"><person-group person-group-type="allauthors"><name><surname>Reback</surname><given-names>J.</given-names></name></person-group>; <etal/><source>Pandas</source>; <year>2020</year>. <pub-id pub-id-type="doi">10.5281/zenodo.3509134</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="conf-proc" id="cit44"><person-group person-group-type="allauthors"><name><surname>Hagberg</surname><given-names>A.</given-names></name>; <name><surname>Swart</surname><given-names>P.</given-names></name>; <name><surname>Chult</surname><given-names>D.</given-names></name></person-group><article-title>Exploring Network Structure, Dynamics,
and Function Using NetworkX</article-title>. In <source>Proceedings
of the 7th Python in Science Conference</source>; <year>2008</year>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Nguyen</surname><given-names>H.</given-names></name>; <name><surname>Case</surname><given-names>D. A.</given-names></name>; <name><surname>Rose</surname><given-names>A. S.</given-names></name>
<article-title>NGLview&#x02013;Interactive
Molecular
Graphics for Jupyter Notebooks</article-title>. <source>Bioinformatics</source>
<year>2018</year>, <volume>34</volume>, <fpage>1241</fpage>&#x02013;<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx789</pub-id>.<pub-id pub-id-type="pmid">29236954</pub-id>
</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="conf-proc" id="cit46"><person-group person-group-type="allauthors"><name><surname>Ester</surname><given-names>M.</given-names></name>; <name><surname>Kriegel</surname><given-names>H.-P.</given-names></name>; <name><surname>Sander</surname><given-names>J.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>A Density-Based
Algorithm for
Discovering Clusters in Large Spatial Databases with Noise</article-title>. In <source>Proceedings of the Second International Conference on
Knowledge Discovery and Data Mining</source>; <publisher-name>AAAI
Press</publisher-name>, <year>1996</year>; pp <fpage>226</fpage>&#x02013;<lpage>231</lpage>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Bushra</surname><given-names>A. A.</given-names></name>; <name><surname>Yi</surname><given-names>G.</given-names></name>
<article-title>Comparative Analysis
Review of Pioneering DBSCAN and Successive Density-Based
Clustering Algorithms</article-title>. <source>IEEE Access</source>
<year>2021</year>, <volume>9</volume>, <fpage>87918</fpage>&#x02013;<lpage>87935</lpage>. <pub-id pub-id-type="doi">10.1109/ACCESS.2021.3089036</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="conf-proc" id="cit48"><person-group person-group-type="allauthors"><name><surname>Ya&#x0015f;ar</surname><given-names>F. G.</given-names></name>; <name><surname>Ulutagay</surname><given-names>G.</given-names></name></person-group><article-title>Challenges
and possible solutions to density based clustering</article-title>. In <source>2016 IEEE 8th International Conference on Intelligent
Systems (IS)</source>; <publisher-name>IEEE</publisher-name>, <year>2016</year>; pp <fpage>492</fpage>&#x02013;<lpage>498</lpage>.</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Hankins</surname><given-names>D.</given-names></name>; <name><surname>Moskowitz</surname><given-names>J. W.</given-names></name>; <name><surname>Stillinger</surname><given-names>F. H.</given-names></name>
<article-title>Water Molecule
Interactions</article-title>. <source>J. Chem. Phys.</source>
<year>1970</year>, <volume>53</volume>, <fpage>4544</fpage>&#x02013;<lpage>4554</lpage>. <pub-id pub-id-type="doi">10.1063/1.1673986</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Berman</surname><given-names>H. M.</given-names></name>; <name><surname>Westbrook</surname><given-names>J.</given-names></name>; <name><surname>Feng</surname><given-names>Z.</given-names></name>; <name><surname>Gilliland</surname><given-names>G.</given-names></name>; <name><surname>Bhat</surname><given-names>T. N.</given-names></name>; <name><surname>Weissig</surname><given-names>H.</given-names></name>; <name><surname>Shindyalov</surname><given-names>I. N.</given-names></name>; <name><surname>Bourne</surname><given-names>P. E.</given-names></name>
<article-title>The Protein Data Bank</article-title>. <source>Nucleic
Acids Res.</source>
<year>2000</year>, <volume>28</volume>, <fpage>235</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>.<pub-id pub-id-type="pmid">10592235</pub-id>
</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Lomize</surname><given-names>M. A.</given-names></name>; <name><surname>Pogozheva</surname><given-names>I. D.</given-names></name>; <name><surname>Joo</surname><given-names>H.</given-names></name>; <name><surname>Mosberg</surname><given-names>H. I.</given-names></name>; <name><surname>Lomize</surname><given-names>A. L.</given-names></name>
<article-title>OPM Database
and PPM Web Server: Resources for Positioning of Proteins in Membranes</article-title>. <source>Nucleic Acids Res.</source>
<year>2012</year>, <volume>40</volume>, <fpage>D370</fpage>&#x02013;<lpage>D376</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr703</pub-id>.<pub-id pub-id-type="pmid">21890895</pub-id>
</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="computer-program" id="cit52"><source>Molecular Operating Environment (MOE)</source>; <publisher-name>Chemical
Computing Group ULC</publisher-name>.</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Maier</surname><given-names>J. A.</given-names></name>; <name><surname>Martinez</surname><given-names>C.</given-names></name>; <name><surname>Kasavajhala</surname><given-names>K.</given-names></name>; <name><surname>Wickstrom</surname><given-names>L.</given-names></name>; <name><surname>Hauser</surname><given-names>K. E.</given-names></name>; <name><surname>Simmerling</surname><given-names>C.</given-names></name>
<article-title>ff14SB: Improving the Accuracy of
Protein Side Chain and Backbone Parameters from ff99SB</article-title>. <source>J. Chem. Theory Comput.</source>
<year>2015</year>, <volume>11</volume>, <fpage>3696</fpage>&#x02013;<lpage>3713</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.5b00255</pub-id>.<pub-id pub-id-type="pmid">26574453</pub-id>
</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Tian</surname><given-names>C.</given-names></name>; <name><surname>Kasavajhala</surname><given-names>K.</given-names></name>; <name><surname>Belfon</surname><given-names>K. A. A.</given-names></name>; <name><surname>Raguette</surname><given-names>L.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Migues</surname><given-names>A. N.</given-names></name>; <name><surname>Bickel</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Pincay</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Simmerling</surname><given-names>C.</given-names></name>
<article-title>ff19SB: Amino-Acid-Specific
Protein Backbone Parameters
Trained against Quantum Mechanics Energy Surfaces in Solution</article-title>. <source>J. Chem. Theory Comput.</source>
<year>2020</year>, <volume>16</volume>, <fpage>528</fpage>&#x02013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.9b00591</pub-id>.<pub-id pub-id-type="pmid">31714766</pub-id>
</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Manning</surname><given-names>G.</given-names></name>; <name><surname>Whyte</surname><given-names>D. B.</given-names></name>; <name><surname>Martinez</surname><given-names>R.</given-names></name>; <name><surname>Hunter</surname><given-names>T.</given-names></name>; <name><surname>Sudarsanam</surname><given-names>S.</given-names></name>
<article-title>The Protein
Kinase Complement of the Human Genome</article-title>. <source>Science</source>
<year>2002</year>, <volume>298</volume>, <fpage>1912</fpage>&#x02013;<lpage>1934</lpage>. <pub-id pub-id-type="doi">10.1126/science.1075762</pub-id>.<pub-id pub-id-type="pmid">12471243</pub-id>
</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Jang</surname><given-names>W. D.</given-names></name>; <name><surname>Kim</surname><given-names>J.-T.</given-names></name>; <name><surname>Kang</surname><given-names>N. S.</given-names></name>
<article-title>The Analysis
of Water Network for
Kinase Selectivity Based on the MD Simulations</article-title>. <source>J. Mol. Liq.</source>
<year>2014</year>, <volume>191</volume>, <fpage>37</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2013.11.023</pub-id>.</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Jang</surname><given-names>W. D.</given-names></name>; <name><surname>Lee</surname><given-names>M. H.</given-names></name>; <name><surname>Kang</surname><given-names>N. S.</given-names></name>
<article-title>Quantitative Assessment
of Kinase
Selectivity Based the Water-Ring Network in Protein Binding Sites
Using Molecular Dynamics Simulations</article-title>. <source>J. Mol.
Liq.</source>
<year>2016</year>, <volume>221</volume>, <fpage>316</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2016.06.013</pub-id>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Williams</surname><given-names>E.</given-names></name>; <name><surname>Bullock</surname><given-names>A. N.</given-names></name>
<article-title>Structural Basis for the Potent and Selective Binding
of LDN-212854 to the BMP Receptor Kinase ALK2</article-title>. <source>Bone</source>
<year>2018</year>, <volume>109</volume>, <fpage>251</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2017.09.004</pub-id>.<pub-id pub-id-type="pmid">28918311</pub-id>
</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Rooney</surname><given-names>L.</given-names></name>; <name><surname>Jones</surname><given-names>C.</given-names></name>
<article-title>Recent Advances in ALK2 Inhibitors</article-title>. <source>ACS Omega</source>
<year>2021</year>, <volume>6</volume>, <fpage>20729</fpage>&#x02013;<lpage>20734</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.1c02983</pub-id>.<pub-id pub-id-type="pmid">34423181</pub-id>
</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Sanvitale</surname><given-names>C. E.</given-names></name>; <name><surname>Kerr</surname><given-names>G.</given-names></name>; <name><surname>Chaikuad</surname><given-names>A.</given-names></name>; <name><surname>Ramel</surname><given-names>M.-C.</given-names></name>; <name><surname>Mohedas</surname><given-names>A. H.</given-names></name>; <name><surname>Reichert</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Triffitt</surname><given-names>J. T.</given-names></name>; <name><surname>Cuny</surname><given-names>G. D.</given-names></name>; <name><surname>Yu</surname><given-names>P. B.</given-names></name>; <name><surname>Hill</surname><given-names>C. S.</given-names></name>; <name><surname>Bullock</surname><given-names>A. N.</given-names></name>
<article-title>A New Class of Small
Molecule Inhibitor of BMP Signaling</article-title>. <source>PLoS One</source>
<year>2013</year>, <volume>8</volume>, <elocation-id>e62721</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0062721</pub-id>.<pub-id pub-id-type="pmid">23646137</pub-id>
</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Kawai</surname><given-names>T.</given-names></name>; <name><surname>Akira</surname><given-names>S.</given-names></name>
<article-title>Toll-Like Receptors
and Their Crosstalk with Other Innate Receptors
in Infection and Immunity</article-title>. <source>Immunity</source>
<year>2011</year>, <volume>34</volume>, <fpage>637</fpage>&#x02013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.006</pub-id>.<pub-id pub-id-type="pmid">21616434</pub-id>
</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Patinote</surname><given-names>C.</given-names></name>; <name><surname>Karroum</surname><given-names>N. B.</given-names></name>; <name><surname>Moarbess</surname><given-names>G.</given-names></name>; <name><surname>Cirnat</surname><given-names>N.</given-names></name>; <name><surname>Kassab</surname><given-names>I.</given-names></name>; <name><surname>Bonnet</surname><given-names>P.-A.</given-names></name>; <name><surname>Deleuze-Masqu&#x000e9;fa</surname><given-names>C.</given-names></name>
<article-title>Agonist and
Antagonist
Ligands of Toll-Like Receptors 7 and 8: Ingenious Tools for Therapeutic
Purposes</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2020</year>, <volume>193</volume>, <fpage>112238</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112238</pub-id>.<pub-id pub-id-type="pmid">32203790</pub-id>
</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Tanji</surname><given-names>H.</given-names></name>; <name><surname>Ohto</surname><given-names>U.</given-names></name>; <name><surname>Shibata</surname><given-names>T.</given-names></name>; <name><surname>Miyake</surname><given-names>K.</given-names></name>; <name><surname>Shimizu</surname><given-names>T.</given-names></name>
<article-title>Structural
Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic
Ligands</article-title>. <source>Science</source>
<year>2013</year>, <volume>339</volume>, <fpage>1426</fpage>&#x02013;<lpage>1429</lpage>. <pub-id pub-id-type="doi">10.1126/science.1229159</pub-id>.<pub-id pub-id-type="pmid">23520111</pub-id>
</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Catterall</surname><given-names>W. A.</given-names></name>
<article-title>Structure
and Regulation of Voltage-Gated Ca2+ Channels</article-title>. <source>Annu. Rev. Cell Dev. Biol.</source>
<year>2000</year>, <volume>16</volume>, <fpage>521</fpage>&#x02013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.cellbio.16.1.521</pub-id>.<pub-id pub-id-type="pmid">11031246</pub-id>
</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Zamponi</surname><given-names>G. W.</given-names></name>; <name><surname>Striessnig</surname><given-names>J.</given-names></name>; <name><surname>Koschak</surname><given-names>A.</given-names></name>; <name><surname>Dolphin</surname><given-names>A. C.</given-names></name>
<article-title>The Physiology,
Pathology, and Pharmacology of Voltage-Gated Calcium Channels and
Their Future Therapeutic Potential</article-title>. <source>Pharmacol.
Rev.</source>
<year>2015</year>, <volume>67</volume>, <fpage>821</fpage><pub-id pub-id-type="doi">10.1124/pr.114.009654</pub-id>.<pub-id pub-id-type="pmid">26362469</pub-id>
</mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Edraki</surname><given-names>N.</given-names></name>; <name><surname>Mehdipour</surname><given-names>A. R.</given-names></name>; <name><surname>Khoshneviszadeh</surname><given-names>M.</given-names></name>; <name><surname>Miri</surname><given-names>R.</given-names></name>
<article-title>Dihydropyridines: Evaluation
of Their Current and Future Pharmacological Applications</article-title>. <source>Drug Discovery Today</source>
<year>2009</year>, <volume>14</volume>, <fpage>1058</fpage>&#x02013;<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2009.08.004</pub-id>.<pub-id pub-id-type="pmid">19729074</pub-id>
</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>G.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Gao</surname><given-names>S.</given-names></name>; <name><surname>Yan</surname><given-names>Z.</given-names></name>; <name><surname>Lei</surname><given-names>J.</given-names></name>; <name><surname>Yan</surname><given-names>N.</given-names></name>
<article-title>Molecular Basis for
Ligand Modulation
of a Mammalian Voltage-Gated Ca2+ Channel</article-title>. <source>Cell</source>
<year>2019</year>, <volume>177</volume>, <fpage>1495</fpage>&#x02013;<lpage>1506</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.04.043</pub-id>.<pub-id pub-id-type="pmid">31150622</pub-id>
</mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Gao</surname><given-names>S.</given-names></name>; <name><surname>Yan</surname><given-names>N.</given-names></name>
<article-title>Structural Basis of
the Modulation of the Voltage-Gated Calcium ion
Channel Cav1.1 by Dihydropyridine Compounds</article-title>. <source>Angew. Chem.</source>
<year>2021</year>, <volume>133</volume>, <fpage>3168</fpage>&#x02013;<lpage>3174</lpage>. <pub-id pub-id-type="doi">10.1002/ange.202011793</pub-id>.</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Yamaguchi</surname><given-names>S.</given-names></name>; <name><surname>Okamura</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>T.</given-names></name>; <name><surname>Adachi-Akahane</surname><given-names>S.</given-names></name>
<article-title>Serine Residue
in the IIIS5-S6 Linker of the L-Type Ca2+ Channel Alpha1C Subunit
is the Critical Determinant of the Action of Dihydropyridine Ca2+
Channel Agonists</article-title>. <source>J. Biol. Chem.</source>
<year>2000</year>, <volume>275</volume>, <fpage>41504</fpage>&#x02013;<lpage>41511</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M007165200</pub-id>.<pub-id pub-id-type="pmid">11022040</pub-id>
</mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Hilger</surname><given-names>D.</given-names></name>
<article-title>The role of
Structural Dynamics in GPCR-Mediated Signaling</article-title>. <source>FEBS J.</source>
<year>2021</year>, <volume>288</volume>, <fpage>2461</fpage>&#x02013;<lpage>2489</lpage>. <pub-id pub-id-type="doi">10.1111/febs.15841</pub-id>.<pub-id pub-id-type="pmid">33871923</pub-id>
</mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Apostolakou</surname><given-names>A. E.</given-names></name>; <name><surname>Baltoumas</surname><given-names>F. A.</given-names></name>; <name><surname>Stravopodis</surname><given-names>D. J.</given-names></name>; <name><surname>Iconomidou</surname><given-names>V. A.</given-names></name>
<article-title>Extended
Human G-Protein Coupled Receptor Network: Cell-Type-Specific Analysis
of G-Protein Coupled Receptor Signaling Pathways</article-title>. <source>J. Proteome Res.</source>
<year>2020</year>, <volume>19</volume>, <fpage>511</fpage>&#x02013;<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00754</pub-id>.<pub-id pub-id-type="pmid">31774292</pub-id>
</mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Cao</surname><given-names>C.</given-names></name>; et al. <article-title>Signaling Snapshots of a Serotonin receptor Activated
by the Prototypical
Psychedelic LSD</article-title>. <source>Neuron</source>
<year>2022</year>, <volume>110</volume>, <fpage>3154</fpage>&#x02013;<lpage>3167</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2022.08.006</pub-id>.<pub-id pub-id-type="pmid">36087581</pub-id>
</mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Gurevich</surname><given-names>V. V.</given-names></name>; <name><surname>Gurevich</surname><given-names>E. V.</given-names></name>
<article-title>GPCR Signaling Regulation:
The Role of GRKs and Arrestins</article-title>. <source>Front. Pharmacol.</source>
<year>2019</year>, <volume>10</volume>, <fpage>125</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00125</pub-id>.<pub-id pub-id-type="pmid">30837883</pub-id>
</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Kolb</surname><given-names>P.</given-names></name>; et al. <article-title>Community Guidelines for GPCR Ligand Bias: IUPHAR Review 32</article-title>. <source>Br. J. Pharmacol.</source>
<year>2022</year>, <volume>179</volume>, <fpage>3651</fpage>&#x02013;<lpage>3674</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15811</pub-id>.<pub-id pub-id-type="pmid">35106752</pub-id>
</mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Denzinger</surname><given-names>K.</given-names></name>; <name><surname>Nguyen</surname><given-names>T. N.</given-names></name>; <name><surname>Noonan</surname><given-names>T.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Bermudez</surname><given-names>M.</given-names></name>
<article-title>Biased Ligands
Differentially Shape the Conformation of the Extracellular Loop Region
in 5-HT2B Receptors</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2020</year>, <volume>21</volume>, <fpage>9728</fpage><pub-id pub-id-type="doi">10.3390/ijms21249728</pub-id>.<pub-id pub-id-type="pmid">33419260</pub-id>
</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>Wacker</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>McCorvy</surname><given-names>J. D.</given-names></name>; <name><surname>Betz</surname><given-names>R. M.</given-names></name>; <name><surname>Venkatakrishnan</surname><given-names>A.</given-names></name>; <name><surname>Levit</surname><given-names>A.</given-names></name>; <name><surname>Lansu</surname><given-names>K.</given-names></name>; <name><surname>Schools</surname><given-names>Z. L.</given-names></name>; <name><surname>Che</surname><given-names>T.</given-names></name>; <name><surname>Nichols</surname><given-names>D. E.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name>; <name><surname>Dror</surname><given-names>R. O.</given-names></name>; <name><surname>Roth</surname><given-names>B. L.</given-names></name>
<article-title>Crystal
Structure of an LSD-Bound Human Serotonin Receptor</article-title>. <source>Cell</source>
<year>2017</year>, <volume>168</volume>, <fpage>377</fpage>&#x02013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.12.033</pub-id>.<pub-id pub-id-type="pmid">28129538</pub-id>
</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name><surname>Haiman</surname><given-names>C. A.</given-names></name>; et al. <article-title>Genetic Variation at the CYP19A1 Locus Predicts Circulating Estrogen
Levels but not Breast Cancer Risk in Postmenopausal Women</article-title>. <source>Cancer Res.</source>
<year>2007</year>, <volume>67</volume>, <fpage>1893</fpage>&#x02013;<lpage>1897</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4123</pub-id>.<pub-id pub-id-type="pmid">17325027</pub-id>
</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Dutta</surname><given-names>U.</given-names></name>; <name><surname>Pant</surname><given-names>K.</given-names></name>
<article-title>Aromatase Inhibitors: Past, Present
and Future in Breast Cancer Therapy</article-title>. <source>Med. Oncol.</source>
<year>2008</year>, <volume>25</volume>, <fpage>113</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1007/s12032-007-9019-x</pub-id>.<pub-id pub-id-type="pmid">17973095</pub-id>
</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>Matthes</surname><given-names>H. W. D.</given-names></name>; <name><surname>Maldonado</surname><given-names>R.</given-names></name>; <name><surname>Simonin</surname><given-names>F.</given-names></name>; <name><surname>Valverde</surname><given-names>O.</given-names></name>; <name><surname>Slowe</surname><given-names>S.</given-names></name>; <name><surname>Kitchen</surname><given-names>I.</given-names></name>; <name><surname>Befort</surname><given-names>K.</given-names></name>; <name><surname>Dierich</surname><given-names>A.</given-names></name>; <name><surname>Le Meur</surname><given-names>M.</given-names></name>; <name><surname>Doll&#x000e9;</surname><given-names>P.</given-names></name>; <name><surname>Tzavara</surname><given-names>E.</given-names></name>; <name><surname>Hanoune</surname><given-names>J.</given-names></name>; <name><surname>Roques</surname><given-names>B. P.</given-names></name>; <name><surname>Kieffer</surname><given-names>B. L.</given-names></name>
<article-title>Loss of
Morphine-Induced Analgesia, Reward Effect and
Withdrawal Symptoms in Mice Lacking the Mu-Opioid-Receptor Gene</article-title>. <source>Nature</source>
<year>1996</year>, <volume>383</volume>, <fpage>819</fpage>&#x02013;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1038/383819a0</pub-id>.<pub-id pub-id-type="pmid">8893006</pub-id>
</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name><surname>Raehal</surname><given-names>K. M.</given-names></name>; <name><surname>Walker</surname><given-names>J. K. L.</given-names></name>; <name><surname>Bohn</surname><given-names>L. M.</given-names></name>
<article-title>Morphine Side Effects in Beta-Arrestin
2 Knockout Mice</article-title>. <source>J. Pharm. Exp. Ther.</source>
<year>2005</year>, <volume>314</volume>, <fpage>1195</fpage>&#x02013;<lpage>1201</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.105.087254</pub-id>.</mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name><surname>Manglik</surname><given-names>A.</given-names></name>; et al. <article-title>Structure-Based Discovery
of Opioid Analgesics with Reduced Side
Effects</article-title>. <source>Nature</source>
<year>2016</year>, <volume>537</volume>, <fpage>185</fpage>&#x02013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1038/nature19112</pub-id>.<pub-id pub-id-type="pmid">27533032</pub-id>
</mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>Kliewer</surname><given-names>A.</given-names></name>; <name><surname>Gillis</surname><given-names>A.</given-names></name>; <name><surname>Hill</surname><given-names>R.</given-names></name>; <name><surname>Schmiedel</surname><given-names>F.</given-names></name>; <name><surname>Bailey</surname><given-names>C.</given-names></name>; <name><surname>Kelly</surname><given-names>E.</given-names></name>; <name><surname>Henderson</surname><given-names>G.</given-names></name>; <name><surname>Christie</surname><given-names>M. J.</given-names></name>; <name><surname>Schulz</surname><given-names>S.</given-names></name>
<article-title>Morphine-Induced Respiratory Depression
is Independent of Beta-Arrestin2 Signalling</article-title>. <source>Br. J. Pharmacol.</source>
<year>2020</year>, <volume>177</volume>, <fpage>2923</fpage>&#x02013;<lpage>2931</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15004</pub-id>.<pub-id pub-id-type="pmid">32052419</pub-id>
</mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name><surname>Levitt</surname><given-names>E. S.</given-names></name>; <name><surname>Abdala</surname><given-names>A. P.</given-names></name>; <name><surname>Paton</surname><given-names>J. F. R.</given-names></name>; <name><surname>Bissonnette</surname><given-names>J. M.</given-names></name>; <name><surname>Williams</surname><given-names>J. T.</given-names></name>
<article-title>Mu Opioid Receptor Activation Hyperpolarizes Respiratory-Controlling
K&#x000f6;lliker&#x02013;Fuse Neurons and Suppresses Post-Inspiratory
Drive</article-title>. <source>Physiol. J.</source>
<year>2015</year>, <volume>593</volume>, <fpage>4453</fpage>&#x02013;<lpage>4469</lpage>. <pub-id pub-id-type="doi">10.1113/JP270822</pub-id>.</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Montandon</surname><given-names>G.</given-names></name>; <name><surname>Ren</surname><given-names>J.</given-names></name>; <name><surname>Victoria</surname><given-names>N. C.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Wickman</surname><given-names>K.</given-names></name>; <name><surname>Greer</surname><given-names>J. J.</given-names></name>; <name><surname>Horner</surname><given-names>R. L.</given-names></name>
<article-title>G-Protein&#x02013;Gated
Inwardly Rectifying Potassium
Channels Modulate Respiratory Depression by Opioids</article-title>. <source>Anesthesiology</source>
<year>2016</year>, <volume>124</volume>, <fpage>641</fpage>&#x02013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1097/ALN.0000000000000984</pub-id>.<pub-id pub-id-type="pmid">26675532</pub-id>
</mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Hetzer</surname><given-names>F.</given-names></name>; <name><surname>Huang</surname><given-names>W.</given-names></name>; <name><surname>Qu</surname><given-names>Q.</given-names></name>; <name><surname>Meyerowitz</surname><given-names>J.</given-names></name>; <name><surname>Kaindl</surname><given-names>J.</given-names></name>; <name><surname>H&#x000fc;bner</surname><given-names>H.</given-names></name>; <name><surname>Skiniotis</surname><given-names>G.</given-names></name>; <name><surname>Kobilka</surname><given-names>B. K.</given-names></name>; <name><surname>Gmeiner</surname><given-names>P.</given-names></name>
<article-title>Structure-Based Evolution
of G Protein-Biased
Mu-Opioid Receptor Agonists</article-title>. <source>Angew. Chem., Int.
Ed.</source>
<year>2022</year>, <volume>61</volume>, <elocation-id>e202200269</elocation-id><pub-id pub-id-type="doi">10.1002/anie.202200269</pub-id>.</mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name><surname>Zhuang</surname><given-names>Y.</given-names></name>; et al. <article-title>Molecular Recognition
of Morphine and Fentanyl by the Human Mu-Opioid
Receptor</article-title>. <source>Cell</source>
<year>2022</year>, <volume>185</volume>, <fpage>4361</fpage>&#x02013;<lpage>4375</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2022.09.041</pub-id>.<pub-id pub-id-type="pmid">36368306</pub-id>
</mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name><surname>Granier</surname><given-names>S.</given-names></name>; <name><surname>Manglik</surname><given-names>A.</given-names></name>; <name><surname>Kruse</surname><given-names>A. C.</given-names></name>; <name><surname>Kobilka</surname><given-names>T. S.</given-names></name>; <name><surname>Thian</surname><given-names>F. S.</given-names></name>; <name><surname>Weis</surname><given-names>W. I.</given-names></name>; <name><surname>Kobilka</surname><given-names>B. K.</given-names></name>
<article-title>Structure
of the Delta-Opioid Receptor
Bound to Naltrindole</article-title>. <source>Nature</source>
<year>2012</year>, <volume>485</volume>, <fpage>400</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1038/nature11111</pub-id>.<pub-id pub-id-type="pmid">22596164</pub-id>
</mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name><surname>Che</surname><given-names>T.</given-names></name>; et al. <article-title>Structure of the Nanobody-Stabilized
Active State of the Kappa Opioid
Receptor</article-title>. <source>Cell</source>
<year>2018</year>, <volume>172</volume>, <fpage>55</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.12.011</pub-id>.<pub-id pub-id-type="pmid">29307491</pub-id>
</mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name><surname>Claff</surname><given-names>T.</given-names></name>; et al. <article-title>Elucidating the Active
Delta-Opioid Receptor Crystal Structure with
Peptide and Small-Molecule Agonists</article-title>. <source>Sci. Adv.</source>
<year>2019</year>, <volume>5</volume>, <elocation-id>eaax9115</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax9115</pub-id>.<pub-id pub-id-type="pmid">31807708</pub-id>
</mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name><surname>Huang</surname><given-names>W.</given-names></name>; et al. <article-title>Structural Insights
into Mu-opioid Receptor Activation</article-title>. <source>Nature</source>
<year>2015</year>, <volume>524</volume>, <fpage>315</fpage>&#x02013;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1038/nature14886</pub-id>.<pub-id pub-id-type="pmid">26245379</pub-id>
</mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name><surname>McCown</surname><given-names>P. J.</given-names></name>; <name><surname>Corbino</surname><given-names>K. A.</given-names></name>; <name><surname>Stav</surname><given-names>S.</given-names></name>; <name><surname>Sherlock</surname><given-names>M. E.</given-names></name>; <name><surname>Breaker</surname><given-names>R. R.</given-names></name>
<article-title>Riboswitch
Diversity and Distribution</article-title>. <source>RNA</source>
<year>2017</year>, <volume>23</volume>, <fpage>995</fpage>&#x02013;<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1261/rna.061234.117</pub-id>.<pub-id pub-id-type="pmid">28396576</pub-id>
</mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name><surname>Nudler</surname><given-names>E.</given-names></name>; <name><surname>Mironov</surname><given-names>A. S.</given-names></name>
<article-title>The Riboswitch Control
of Bacterial Metabolism</article-title>. <source>Trends Biochem. Sci.</source>
<year>2004</year>, <volume>29</volume>, <fpage>11</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2003.11.004</pub-id>.<pub-id pub-id-type="pmid">14729327</pub-id>
</mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name><surname>Peselis</surname><given-names>A.</given-names></name>; <name><surname>Serganov</surname><given-names>A.</given-names></name>
<article-title>Themes and Variations
in Riboswitch Structure and Function</article-title>. <source>Biochim.
Biophys.</source>
<year>2014</year>, <volume>1839</volume>, <fpage>908</fpage>&#x02013;<lpage>918</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.02.012</pub-id>.</mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name><surname>Lee</surname><given-names>E. R.</given-names></name>; <name><surname>Blount</surname><given-names>K. F.</given-names></name>; <name><surname>Breaker</surname><given-names>R. R.</given-names></name>
<article-title>Roseoflavin is a Natural Antibacterial
Compound that Binds to FMN Riboswitches and Regulates Gene Expression</article-title>. <source>RNA Biol.</source>
<year>2009</year>, <volume>6</volume>, <fpage>187</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.4161/rna.6.2.7727</pub-id>.<pub-id pub-id-type="pmid">19246992</pub-id>
</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name><surname>Serganov</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>L.</given-names></name>; <name><surname>Patel</surname><given-names>D. J.</given-names></name>
<article-title>Coenzyme Recognition and Gene Regulation
by a Flavin Mononucleotide Riboswitch</article-title>. <source>Nature</source>
<year>2009</year>, <volume>458</volume>, <fpage>233</fpage>&#x02013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1038/nature07642</pub-id>.<pub-id pub-id-type="pmid">19169240</pub-id>
</mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name><surname>Laing</surname><given-names>L. G.</given-names></name>; <name><surname>Gluick</surname><given-names>T. C.</given-names></name>; <name><surname>Draper</surname><given-names>D. E.</given-names></name>
<article-title>Stabilization
of RNA Structure by
Mg Ions: Specific and Non-specific Effects</article-title>. <source>J. Mol. Biol.</source>
<year>1994</year>, <volume>237</volume>, <fpage>577</fpage>&#x02013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1994.1256</pub-id>.<pub-id pub-id-type="pmid">8158638</pub-id>
</mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="computer-program" id="cit97"><source>Schr&#x000f6;dinger Release 2024-1: Maestro</source>; <publisher-name>Schr&#x000f6;dinger LLC</publisher-name>, <year>2024</year>.</mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="book" id="cit98"><person-group person-group-type="allauthors"><name><surname>Ballesteros</surname><given-names>J. A.</given-names></name>; <name><surname>Weinstein</surname><given-names>H.</given-names></name></person-group><article-title>Integrated
methods for the construction of three-dimensional models and computational
probing of structure-function relations in G protein-coupled receptors</article-title>. In <source>Methods Neurosciences</source>; <person-group person-group-type="editor"><name><surname>Sealfon</surname><given-names>S. C.</given-names></name></person-group>, Ed.; <publisher-name>Academic
Press</publisher-name>, <year>1995</year>; Vol. <volume>25</volume>; pp <fpage>366</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1016/S1043-9471(05)80049-7</pub-id>.</mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name><surname>O&#x02019;Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name>
<article-title>Open Babel:
An Open Chemical Toolbox</article-title>. <source>J. Cheminform.</source>
<year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.<pub-id pub-id-type="pmid">21982300</pub-id>
</mixed-citation></ref></ref-list></back></article>